HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is an 80-year-old male with a history of coronary artery disease (CAD) status post-coronary artery bypass graft (CABG), cerebrovascular accident (CVA), hypertension (HTN), chronic obstructive pulmonary disease (COPD), and a new diagnosis of metastatic liver cancer. The patient presents with sepsis, hypotension, and chest/shoulder pain, which may be related to pneumonia (PNA), aspiration pneumonitis, or esophageal process. He also has abnormal liver function tests (LFTs), metabolic acidosis, acute kidney injury (ARF), and anemia.

The patient's laboratory results show:

* White blood cell count (WBC): 14.7-15.8 K/uL
* Hemoglobin (Hb): 9.7 g/dL
* Platelet count (Plt): 217-250 K/uL
* Blood urea nitrogen (BUN): 28.8 mg/dL
* Creatinine (Cr): 2.8-3.0 mg/dL
* Lactic acid: 1.6 mmol/L
* Albumin: 2.2 g/dL
* Calcium (Ca++): 7.7 mg/dL
* Magnesium (Mg++): 2.4 mg/dL
* Phosphorus (PO4): 4.0 mg/dL

The patient's vital signs are:

* Temperature (Tmax): 35.6°C
* Heart rate (HR): 91 bpm
* Blood pressure (BP): 112/51 mmHg
* Respiratory rate (RR): 16 breaths per minute
* Oxygen saturation (SpO2): 100%

The patient's medical complications and potential medical complications are:

1. Sepsis: The patient meets the criteria for sepsis, and the most likely source is pneumonia (PNA) or a hepatobiliary source.
2. Hypotension: The patient has hypotension, which may be related to hypovolemia, sepsis, or other causes. The differential diagnosis includes cardiogenic shock, pulmonary embolism (PE), pericardial effusion/tamponade, and adrenal insufficiency.
3. Chest/shoulder pain: The patient has chest/shoulder pain, which may be related to atypical coronary syndrome, referred pain from pleura, esophageal process, or musculoskeletal pain.
4. Metabolic acidosis: The patient has metabolic acidosis, which may be related to lactic acidosis, accumulation of organic anions in ARF, or other causes.
5. Acute kidney injury (ARF): The patient has ARF, which may be related to pre-renal azotemia, acute tubular necrosis (ATN), or other causes.
6. Abnormal liver function tests (LFTs): The patient has abnormal LFTs, which may be related to diffuse metastatic disease, intrahepatic cholestasis, or biliary obstruction.
7. Anemia: The patient has anemia, which may be related to Fe-deficiency, chronic GI blood loss, or other causes.

The patient's treatment plan includes:

1. Fluid boluses to maintain central venous pressure (CVP) > 9 mmHg and mean arterial pressure (MAP) > 65 mmHg.
2. Continuous infusion of zosyn for Gram-negative and anaerobic coverage.
3. Restarting vancomycin and rechecking trough levels.
4. Blood cultures pending, with plans to send urine, sputum, and C. diff toxin cultures.
5. Aspiration precautions.
6. Treatment for sepsis and hypovolemia, including aggressive fluid repletion and monitoring of urine output.
7. Continuous telemetry and frequent blood pressure monitoring.
8. Consideration of levophed for MAP support.
9. A-line placement for better blood pressure monitoring if necessary.
10. GI workup pending, including esophagogastroduodenoscopy (EGD) and/or endoscopic ultrasound (EUS).
11. Consideration of beta-blocker therapy when blood pressure is stable.
12. Holding antihypertensives while blood pressure is low.
13. Holding crestor due to elevated LFTs.
14. Avoiding NSAIDs, ibuprofen, and tylenol due to ARF and risk of gastrointestinal bleeding.
15. Monitoring serum electrolytes closely.

The patient's code status is full code."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with a history of CAD, CVA, HTN, COPD, and esophageal cancer metastatic to the liver. He was admitted to the ICU with sepsis, hypotension, and atypical chest pain. The patient has a complex medical history, including a recent CABG, and is currently receiving treatment for sepsis, hypovolemia, and respiratory failure. He is also experiencing abdominal pain, diarrhea, and anemia.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely to worsen if not properly treated, leading to organ dysfunction and potentially life-threatening complications.
2. Hypotension: The patient's hypotension is likely to persist if not properly treated, leading to organ dysfunction and potentially life-threatening complications.
3. Respiratory Failure: The patient's respiratory failure is likely to worsen if not properly treated, leading to hypoxia and potentially life-threatening complications.
4. Acute Kidney Injury (AKI): The patient's AKI is likely to worsen if not properly treated, leading to chronic kidney disease and potentially life-threatening complications.
5. Liver Dysfunction: The patient's liver dysfunction is likely to worsen if not properly treated, leading to coagulopathy and potentially life-threatening complications.
6. Pancreatitis: The patient's pancreatitis is likely to worsen if not properly treated, leading to pancreatic necrosis and potentially life-threatening complications.
7. Aspiration Pneumonia: The patient's aspiration pneumonia is likely to worsen if not properly treated, leading to respiratory failure and potentially life-threatening complications.
8. Deep Vein Thrombosis (DVT): The patient's DVT is likely to worsen if not properly treated, leading to pulmonary embolism and potentially life-threatening complications.
9. Gastrointestinal Bleeding (GIB): The patient's GIB is likely to worsen if not properly treated, leading to hypovolemia and potentially life-threatening complications.

Recommendations:

1. Continue treatment for sepsis, hypovolemia, and respiratory failure.
2. Monitor the patient's vital signs and lab results closely to adjust treatment as needed.
3. Consider adding antibiotics to the patient's treatment plan if the patient's infection is not responding to treatment.
4. Monitor the patient's kidney function and adjust treatment as needed to prevent AKI.
5. Consider adding a vasopressor to the patient's treatment plan if the patient's blood pressure is not responding to treatment.
6. Monitor the patient's liver function and adjust treatment as needed to prevent liver dysfunction.
7. Consider adding a pancreatic enzyme supplement to the patient's treatment plan if the patient's pancreatitis is not responding to treatment.
8. Monitor the patient's respiratory status and adjust treatment as needed to prevent respiratory failure.
9. Consider adding a DVT prophylaxis to the patient's treatment plan if the patient is at high risk for DVT.
10. Monitor the patient's gastrointestinal status and adjust treatment as needed to prevent GIB."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 100%
   ABG: 7.37/24/84.[**Numeric Identifier 117**]/15/-9
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following potential medical complications can arise:

1. Sepsis: The patient's diagnosis of sepsis is a critical condition that requires immediate attention. The patient's vital signs, including temperature, heart rate, and blood pressure, are unstable, and the patient is at risk of further deterioration.
2. Respiratory failure: The patient's respiratory status is concerning, with a large hiatal hernia and increased left perihilar opacity on CXR, which may indicate aspiration or aspiration pneumonia. The patient's oxygen saturation is 100%, but this may not be a reliable indicator of respiratory function.
3. Acute kidney injury (ARF): The patient's creatinine level is elevated, and the BUN/Cr ratio suggests pre-renal azotemia. The patient's urine output is low, and the patient is at risk of further kidney damage.
4. Liver dysfunction: The patient's liver function tests (LFTs) are abnormal, with elevated bilirubin and alkaline phosphatase levels. The patient's albumin level is low, and the INR is elevated, suggesting impaired liver synthetic function.
5. Electrolyte imbalance: The patient's electrolyte levels are abnormal, with hypermagnesemia and hyperphosphatemia. The patient's potassium level is not reported, but the patient is at risk of developing hypokalemia.
6. Metabolic acidosis: The patient's anion gap is elevated, and the patient's serum osmolality is low. The patient's lactate level is not reported, but the patient is at risk of developing lactic acidosis.
7. Asymmetrical leg edema: The patient's leg edema is concerning, and the patient is at risk of developing deep vein thrombosis (DVT) or pulmonary embolism (PE).
8. Gastrointestinal bleeding: The patient's history of gastrointestinal bleeding is concerning, and the patient is at risk of further bleeding.
9. Cardiac complications: The patient's history of coronary artery disease (CAD) and previous CABG surgery increases the risk of cardiac complications, including myocardial infarction or cardiac arrhythmias.
10. Infection: The patient's diagnosis of sepsis is a critical condition that requires immediate attention. The patient's white blood cell count is elevated, and the patient is at risk of developing further infections.

The patient's treatment plan should prioritize addressing these potential complications, including:

1. Sepsis: The patient should receive antibiotics and supportive care, including fluid resuscitation and vasopressor support.
2. Respiratory failure: The patient should receive oxygen therapy and mechanical ventilation if necessary.
3. ARF: The patient should receive fluid therapy and vasopressor support, and the patient's urine output should be monitored closely.
4. Liver dysfunction: The patient should receive supportive care, including nutritional support and liver function monitoring.
5. Electrolyte imbalance: The patient should receive electrolyte replacement therapy, and the patient's electrolyte levels should be monitored closely.
6. Metabolic acidosis: The patient should receive bicarbonate therapy and the patient's anion gap should be monitored closely.
7. Asymmetrical leg edema: The patient should receive compression stockings and the patient's leg edema should be monitored closely.
8. Gastrointestinal bleeding: The patient should receive supportive care, including blood transfusions and gastrointestinal bleeding prophylaxis.
9. Cardiac complications: The patient should receive cardiac monitoring and supportive care, including beta-blocker therapy if necessary.
10. Infection: The patient should receive antibiotics and supportive care, including fluid resuscitation and vasopressor support.

The patient's code status is full code, indicating that the patient is willing to receive all possible medical interventions to save their life."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's - Diffuse metastatic disease (? esophageal primary) by
   RUQ U/S, but could not adequately visualize biliary tree. Low
   albumin/elevated INR suggest diminished synthetic function. Markedly
   elevated Alk phos/AST with T Bili 2X ULN suggests a cholestatic pattern
   of liver injury such as intrahepatic cholestasis (i.e. in the setting
   of sepsis) or biliary obstruction (given high amylase/lipase) although
   no epigastric tenderness. 300>AST>ALT invokes ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -tumor markers
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's daily progress note, the following potential medical complications can arise:

1. Sepsis: The patient is already diagnosed with sepsis, and there is a high risk of developing further complications such as organ failure, septic shock, and death.
2. Hypotension: The patient's blood pressure is low, and there is a risk of further hypotension, which can lead to organ failure, particularly in the kidneys and liver.
3. Acute Respiratory Failure (ARF): The patient's oxygen saturation is 100%, but there is a risk of developing ARF due to the patient's underlying lung disease and sepsis.
4. Acute Kidney Injury (AKI): The patient's creatinine levels are elevated, and there is a risk of developing AKI, which can lead to chronic kidney disease and end-stage renal disease.
5. Metabolic Acidosis: The patient has a gap metabolic acidosis, which can lead to further complications such as cardiac arrhythmias, seizures, and death.
6. Liver Failure: The patient has elevated liver enzymes, and there is a risk of developing liver failure, which can lead to coagulopathy, jaundice, and death.
7. Aspiration Pneumonia: The patient has a high risk of developing aspiration pneumonia due to his underlying lung disease, sepsis, and dysphagia.
8. Deep Vein Thrombosis (DVT): The patient has a high risk of developing DVT due to his immobility and underlying malignancy.
9. Pulmonary Embolism (PE): The patient has a high risk of developing PE due to his immobility and underlying malignancy.
10. Cardiac Complications: The patient has a history of coronary artery disease and has undergone coronary artery bypass grafting (CABG), and there is a risk of developing cardiac complications such as arrhythmias, heart failure, and myocardial infarction.
11. Gastrointestinal Complications: The patient has a high risk of developing gastrointestinal complications such as bleeding, perforation, and obstruction due to his underlying malignancy and sepsis.
12. Neurological Complications: The patient has a high risk of developing neurological complications such as seizures, stroke, and encephalopathy due to his underlying malignancy and sepsis.

To mitigate these potential complications, the patient should receive aggressive fluid resuscitation, vasopressor support, and antimicrobial therapy. The patient's airway, breathing, and circulation should be closely monitored, and the patient should be managed in a critical care setting."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 80-year-old male who has been admitted to the ICU with sepsis, hypotension, and a new diagnosis of metastatic liver cancer. The patient has a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease, and has undergone coronary artery bypass grafting.

The patient's current vital signs are as follows:

* Temperature: 35.6°C (96°F)
* Heart rate: 91 beats per minute
* Blood pressure: 112/51 mmHg
* Respiratory rate: 16 breaths per minute
* Oxygen saturation: 100%

The patient has a severe sepsis with a suspected source of infection in the lungs or liver. He has a central venous catheter and a pulmonary artery catheter in place. His blood cultures are pending, and he is receiving broad-spectrum antibiotics.

The patient has a history of chronic steroid therapy, which may be contributing to his hypotension. He is also receiving vasopressors to support his blood pressure.

The patient's laboratory results are as follows:

* White blood cell count: 14.7 x 10^9/L
* Hematocrit: 30.4%
* Platelet count: 250 x 10^9/L
* Blood urea nitrogen: 17.6 mmol/L
* Creatinine: 2.8 mg/dL
* Glucose: 176 mg/dL
* Lactic acid: 1.6 mmol/L
* Albumin: 2.2 g/dL
* LDH: 471 IU/L
* Calcium: 7.7 mg/dL
* Magnesium: 2.4 mg/dL
* Phosphate: 4.0 mg/dL

The patient's imaging studies show a large hiatal hernia and increased left perihilar opacity on the chest X-ray, which is concerning for aspiration or aspiration pneumonia.

The patient's medical conditions include sepsis, hypotension, chronic obstructive pulmonary disease, and metastatic liver cancer. His potential medical complications include:

* Sepsis-related organ dysfunction
* Hypotension-related organ dysfunction
* Acute respiratory distress syndrome (ARDS)
* Acute kidney injury (AKI)
* Hepatic dysfunction
* Gastrointestinal bleeding
* Deep vein thrombosis (DVT)
* Pulmonary embolism (PE)

The patient's treatment plan includes:

* Broad-spectrum antibiotics for suspected sepsis
* Vasopressors to support blood pressure
* Fluid resuscitation to maintain central venous pressure and mean arterial pressure
* Continuous monitoring of vital signs and laboratory results
* Consideration of invasive monitoring, such as a pulmonary artery catheter
* Consultation with specialists, such as a pulmonologist and a gastroenterologist
* Consideration of palliative care and end-of-life care discussions"
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   1 L LR bolus x 2
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 8, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- diffuse rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -blood Cx pending; will send urine, sputum Cx, c. diff toxin
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is a 80-year-old male with a history of CAD, CVA, HTN, COPD, and esophageal cancer metastatic to the liver. He is currently in the ICU due to sepsis, hypotension, and respiratory failure.

The patient's vital signs are:

* T-max: 35.6°C
* T-current: 35.6°C
* HR: 91 bpm
* BP: 112/51 mmHg
* RR: 16 inspirations per minute
* SpO2: 100%
* Heart rhythm: Sinus rhythm

The patient's physical examination reveals:

* General: Awake, cachectic, dysarthric; NAD
* HEENT: PERRL; sclera anicteric; right-sided lower facial droop
* Neck: R IJ in place; CVP 8, left-sided JVD not appreciated
* CV: RRR, nl S1S2, no m/r/g
* PULM: Diffuse rhonchi on left, no wheeze, rales
* ABD: Soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
* EXT: Warm, dry; +PP, 1+ pitting edema, L > R
* NEURO: A+Ox3; complete right-sided hemiparesis of arm/leg; hyperreflexic at right patella, hyporeflexic at left patella

The patient's lab results are:

* WBC: 14.7-15.8 K/uL
* Hct: 30.4-28.8%
* Plt: 250-217 K/uL
* Cr: 3.0-2.8 mg/dL
* TCO2: 14 mmol/L
* Glucose: 176-155 mg/dL
* Other labs: PT/PTT/INR: 15.1/25.6/1.3; CK/CKMB/Troponin-T: 471//; ALT/AST: 51/279 IU/L; Alk Phos/T Bili: 755/2.8 mg/dL; Amylase/Lipase: 155/430 IU/L

The patient's medical conditions and potential complications are:

* Sepsis: The patient meets the criteria for sepsis, with hypothermia, leukocytosis, acidosis, and evidence of an infectious focus. The likely source of infection is pneumonia or a hepatobiliary source, with C. diff as a possible contributing factor.
* Hypotension: The patient's hypotension may be due to hypovolemia, sepsis, or a combination of both. The patient has received 6 L of fluid so far, and remains hypotensive.
* Chest/shoulder pain: The patient's atypical chest pain may be due to ACS, referred pain from the pleura, or musculoskeletal pain.
* Gap metabolic acidosis: The patient's acidosis may be due to lactic acidosis, accumulation of organic anions in ARF, or a combination of both.
* ARF: The patient's BUN/Cr ratio suggests pre-renal azotemia, with a possible contribution from ATN.
* Asymmetrical LE edema: The patient's edema may be due to DVT or PE.
* Abnormal LFT's: The patient's LFT's are trending down, with a possible cholestatic pattern of liver injury.
* Dysphagia: The patient's dysphagia may be due to esophageal CA, hiatal hernia, or aspiration.
* CAD s/p CABG: The patient's CAD may be contributing to his hypotension and chest pain.
* COPD: The patient's COPD is not acutely exacerbating his condition.
* Anemia: The patient's anemia may be due to Fe-deficiency, chronic GI blood loss, or ACD.
* HTN: The patient's HTN is not currently a concern, given his low BP.
* Hyperlipidemia: The patient's hyperlipidemia is not currently a concern, given his elevated LFT's.
* Chronic back pain: The patient's back pain may be due to musculoskeletal pain, or may be a symptom of his underlying conditions.

The patient's potential medical complications include:

* Respiratory failure
* Cardiac arrest
* Sepsis-induced organ failure
* ARF
* DVT/PE
* GIB
* Liver failure
* Kidney failure

The patient's treatment plan includes:

* Fluid boluses to maintain CVP >9 and MAP >65
* Continuous infusion of zosyn for G- and anaerobic-resistant gram-negative bacteria
* Restarting vanco and rechecking trough levels
* Blood cultures and urine cultures
* Aspiration precautions
* Continuous monitoring of vital signs and lab results
* Regular insulin sliding scale for glycemic control
* Prophylaxis for DVT and stress ulcer
* Code status: Full code

The patient's family has been informed of his condition, and his granddaughter has been contacted. The patient's code status is full code, and he is to be treated accordingly."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   Patient received LR boluses 1 L/hr since arrival in ICU.
   0900 pt c/o severe
gas pain
 beginning in his rectum and radiating up
   into his abdomen, chest, and arms; VSS, EKG showed new lateral ST
   depressions; given O2, [**Year (4 digits) 119**], morphine IV, SL nitro x 2 with good relief
   of pain, but hypotensive to 80s systolic with 2^nd dose of nitro;
   heparin gtt started for UA, cont. 500 cc fluid boluses q30 min to
   achieve CVP 8-12
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems: as above
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 6, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- scattered rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #UA
 new lateral ST-dep assoc. with atypical chest pain, different
   from pain described on admission
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -add azithromycin for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin and sputum Cx if
   possible
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   Patient received LR boluses 1 L/hr since arrival in ICU.
   0900 pt c/o severe
gas pain
 beginning in his rectum and radiating up
   into his abdomen, chest, and arms; VSS, EKG showed new lateral ST
   depressions; given O2, [**Year (4 digits) 119**], morphine IV, SL nitro x 2 with good relief
   of pain, but hypotensive to 80s systolic with 2^nd dose of nitro;
   heparin gtt started for UA, cont. 500 cc fluid boluses q30 min to
   achieve CVP 8-12
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems: as above
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 6, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- scattered rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #UA
 new lateral ST-dep assoc. with atypical chest pain, different
   from pain described on admission
   .
   #Sepsis - Meets criteria for sepsis given hypothermia, leukocytosis,
   acidosis and evidence for an infectious focus; most likely PNA (may
   account for referred pain/pleuritic pain) vs. hepatobiliary source,
   also c/f C. diff given loose stools; location of opacity on CXR c/f
   aspiration pneumonitis vs. PNA
   -fluid boluses to maintain CVP >[**9-24**], MAP > 65; consider starting
   levophed if MAP inadequate with frequent fluid challenges; may require
   A-line for better BP monitoring if doesn't improve
   -cont. zosyn for G-/anaerobic resp(given aspiration risk)/GI flora
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco, recheck
   trough prior to 3rd dose
   -add azithromycin for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin and sputum Cx if
   possible
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above); less likely are cardiogenic shock
   (atypical chest pain in light of his PMH but unchanged EKG, first set
   of CE WNL, no clinical s/sx of CHF), PE (mildly hypoxic but not
   tachycardic, no evidence of RH strain on EKG), pericardial
   effusion/tamponade (JVP not elevated, no distant heart sounds), and
   adrenal insufficiency (on chronic steroid therapy); has received 6 L so
   far and remains hypotensive
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -no ischemic changes on EKG; first cycle CE's neg @ OSH, cont. to cycle
   -TTE to eval. for PA pressures, RH strain, baseline LV fxn; kidney fxn
   likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on chronic steroid
   therapy and received a dose of HC @ OSH ED
   -telemetry
   .
   #Chest/shoulder pain - [**Month (only) 8**] represent atypical ACS, first set of CE's
   negative, EKG did show TWI inferiorly but no evolving changes; may also
   represent referred pain from pleura in the setting of PNA or esophageal
   process/hiatal hernia reflux, intraabdominal process
   (splenic/diaphragmatic abscess), or musculoskeletal pain
   -recheck EKG with recurrent pain
   -tx for PNA as above
   -further GI w/u pending
   -lidocaine patch for analgesia
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion; low suspicion for ingestion ([**Month (only) 119**],
   tylenol) and denies ETOH; gap narrowing; calc osms = 317
   -ABG suggestive of concomitant respiratory alkalosis
   -serum osms (to calculate gap), [**Month (only) 119**], tylenol
   -urine ketones
   .
   #ARF - BUN/Cr ratio suggests pre-renal azotemia, ddx includes ATN in
   the setting of hypotension and/or sepsis; likely accounts for
   hypermagnesemia and hyperphosphatemia; foley in place, draining so low
   c/f obstruction
   -fluid challenge, BP support as above
   -U/A, culture, sediment, lytes
   -monitor serum lytes closely
   -UOP 60 cc (.86 cc/kg) during first hour in ICU
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of liver injury such as intrahepatic cholestasis
   (i.e. in the setting of sepsis) or biliary obstruction (given high
   amylase/lipase) although no epigastric tenderness. 300>AST>ALT invokes
   ETOH, but he denies.
   -GI C/S re: ERCP vs. EUS, further imaging, biopsy
   -CEA markedly elevated
   .
   #Dysphagia - c/f esophageal CA (in light of weight loss, h/o ETOH/tob
   use); may also be accounting for referred pain to left shoulder; risk
   factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD vs. ERCP
   -aspiration precautions
   -consider speech/swallow C/S
   .
   #CAD s/p CABG
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]; gather info re: CAD ? stent in case bleeds
   -cycle CE's
   -telemetry
   -would likely benefit from beta(1)-blocker when BP stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -holding steroids as indication and dosing unclear at this time
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -T&C, x-fuse for < 24%
   -iron studies, retic ct, B12, folate
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N - volume depleted by exam
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP >
   -NPO in case a procedure required
   -monitor lytes (ARF)
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with a history of CAD, CVA, HTN, COPD, and esophageal cancer with metastasis to the liver. He was admitted to the ICU with sepsis, hypotension, and chest pain. He has a new diagnosis of CA metastatic to the liver and is being treated for sepsis and hypovolemia. He has also been diagnosed with ARF, metabolic acidosis, and hyperlipidemia. He is at risk for aspiration, DVT, and GI bleeding.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely due to pneumonia or a hepatobiliary source, and he is at risk for further complications such as organ failure, shock, and death.
2. Hypotension: The patient's hypotension is likely due to sepsis, hypovolemia, or a combination of both. He is at risk for further complications such as organ failure, shock, and death.
3. ARF: The patient's ARF is likely due to pre-renal azotemia, and he is at risk for further complications such as electrolyte imbalances, acidosis, and death.
4. Metabolic Acidosis: The patient's metabolic acidosis is likely due to lactic acidosis or accumulation of organic anions in ARF, and he is at risk for further complications such as electrolyte imbalances and acidosis.
5. Hyperlipidemia: The patient's hyperlipidemia is likely due to his underlying medical conditions, and he is at risk for further complications such as pancreatitis, atherosclerosis, and cardiovascular disease.
6. Aspiration: The patient is at risk for aspiration due to his esophageal cancer and hiatal hernia, and he is at risk for further complications such as pneumonia, respiratory failure, and death.
7. DVT: The patient is at risk for DVT due to his malignancy and immobility, and he is at risk for further complications such as pulmonary embolism, deep vein thrombosis, and death.
8. GI Bleeding: The patient is at risk for GI bleeding due to his esophageal cancer, liver metastasis, and chronic GI blood loss, and he is at risk for further complications such as anemia, hemorrhage, and death.

Recommendations:

1. Continue to treat the patient's sepsis and hypovolemia with aggressive fluid repletion and vasopressors as needed.
2. Monitor the patient's ARF closely and consider dialysis if necessary.
3. Continue to manage the patient's metabolic acidosis with bicarbonate therapy and electrolyte replacement.
4. Monitor the patient's hyperlipidemia and consider lipid-lowering therapy if necessary.
5. Continue to monitor the patient for signs of aspiration and take measures to prevent it.
6. Monitor the patient for signs of DVT and consider prophylactic anticoagulation if necessary.
7. Monitor the patient for signs of GI bleeding and consider endoscopy or other diagnostic tests if necessary.
8. Continue to manage the patient's underlying medical conditions, including his esophageal cancer, CAD, CVA, HTN, COPD, and hyperlipidemia."
182947.0,210248,2182-08-23 06:50:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   Patient received LR boluses 1 L/hr since arrival in ICU.
   0900 pt c/o severe
gas pain
 beginning in his rectum and radiating up
   into his abdomen, chest, and arms; VSS, EKG showed new lateral ST
   depressions; given O2, [**Year (4 digits) 119**], morphine IV, SL nitro x 2 with good relief
   of pain, but hypotensive to 80s systolic with 2^nd dose of nitro;
   heparin gtt started for UA, cont. 500 cc fluid boluses q30 min to
   achieve CVP 8-12
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems: as above
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 6, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- scattered rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Year (2) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   -500 cc LR boluses q30 min to achieve CVP >[**9-24**], MAP > 65; consider
   starting levophed if MAP still inadequate
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**3-28**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**3-28**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**2-16**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch when more stable
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -TTE to eval. for FWA, PA pressures, RH strain, baseline LV fxn; kidney
   fxn likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require warrant more attention;
   foley in place, draining so low c/f obstruction
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   -systemic anticoagulation for ACS
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO in case a procedure required
   -monitor lytes, replete PRN
   .
   #PPx - PPI, heparin gtt
   .
   #Access - R IJ, PIV; art-line to be placed
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
 PRESEP CATHETER - START [**2182-8-23**] 12:59 AM
   Patient received LR boluses 1 L/hr since arrival in ICU.
   0900 pt c/o severe
gas pain
 beginning in his rectum and radiating up
   into his abdomen, chest, and arms; VSS, EKG showed new lateral ST
   depressions; given O2, [**Year (4 digits) 119**], morphine IV, SL nitro x 2 with good relief
   of pain, but hypotensive to 80s systolic with 2^nd dose of nitro;
   heparin gtt started for UA, cont. 500 cc fluid boluses q30 min to
   achieve CVP 8-12
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history: n/a
   Review of systems is unchanged from admission except as noted below
   Review of systems: as above
   Flowsheet Data as of  [**2182-8-23**] 06:49 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.6
C (96
   Tcurrent: 35.6
C (96
   HR: 91 (79 - 91) bpm
   BP: 112/51(67) {98/45(35) - 112/51(67)} mmHg
   RR: 16 (16 - 19) insp/min
   SpO2: 100%
   Heart rhythm: SR (Sinus Rhythm)
    CVP: 6 (6 - 8)mmHg
   SvO2: 67%
                                Total In:
                                2,000 mL
   PO:
                                TF:
   IVF:
   2,000 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                    150 mL
   Urine:
   150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                  1,850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 2L
   SpO2: 100%
   ABG: 7.37/24/84/15/-9
   Physical Examination
   GEN- Awake, cachectic, dysarthric; NAD
   HEENT- PERRL; sclera anicteric; right-sided lower facial droop
   NECK- R IJ in place [**Location (un) 118**] CVP 6, leftsided JVD not appreciated
   CV- RRR nl S1S2 no m/r/g
   PULM- scattered rhonchi on left, no wheeze, rales
   ABD- soft, NTND, +BS; tender hepatomegaly, no appreciable ascites
   EXT- warm, dry; +PP, 1+ pitting edema, L > R
   NEURO- A+Ox3; complete right-sided hemiparesis of arm/leg;
   hyperreflexic at right patella, hyporeflexic at left patella
   Labs / Radiology
   217 K/uL
   9.7 g/dL
   155 mg/dL
   2.8 mg/dL
   15 mEq/L
   3.9 mEq/L
   88 mg/dL
   112 mEq/L
   140 mEq/L
   28.8 %
   15.8 K/uL
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
   WBC
   14.7
   15.8
   Hct
   30.4
   28.8
   Plt
   250
   217
   Cr
   3.0
   2.8
   TCO2
   14
   Glucose
   176
   155
   Other labs: PT / PTT / INR:15.1/25.6/1.3, CK / CKMB / Troponin-T:471//,
   ALT / AST:51/279, Alk Phos / T Bili:755/2.8, Amylase / Lipase:155/430,
   Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %, Eos:0.1
   %, Lactic Acid:1.6 mmol/L, Albumin:2.2 g/dL, LDH:471 IU/L, Ca++:7.7
   mg/dL, Mg++:2.4 mg/dL, PO4:4.0 mg/dL
   Microbiology: [**8-22**] BCx pending
   Imaging:
   RUQ U/S - 1. Findings are consistent with inumerable metastatic foci in
   the liver.
   2. The gallbladder is not reliably identified although there is no
   evidence
   of distention.
   CXR (PA/lat) 1. Large hiatal hernia.
   2. Increased left perihilar opacity. Findings concerning for aspiration
   or
   aspiration pneumonia.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Year (2) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   -500 cc LR boluses q30 min to achieve CVP >[**9-24**], MAP > 65; consider
   starting levophed if MAP still inadequate
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**3-28**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**3-28**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**2-16**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch when more stable
   -aspiration precautions
   .
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -TTE to eval. for FWA, PA pressures, RH strain, baseline LV fxn; kidney
   fxn likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   .
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   .
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require warrant more attention;
   foley in place, draining so low c/f obstruction
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   .
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   -systemic anticoagulation for ACS
   .
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO in case a procedure required
   -monitor lytes, replete PRN
   .
   #PPx - PPI, heparin gtt
   .
   #Access - R IJ, PIV; art-line to be placed
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: NPO
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Prophylaxis:
   DVT: Heparin gtt
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with a history of CAD, CVA, HTN, COPD, and malignancy, currently admitted to the ICU with sepsis, hypotension, and respiratory failure. He has a new diagnosis of CA metastatic to the liver and is experiencing severe gas pain, lateral ST depressions on EKG, and signs of liver dysfunction. He is receiving aggressive fluid repletion, vasopressors, and antibiotics for sepsis. His laboratory results show anemia, metabolic acidosis, acute kidney injury, and abnormal liver function tests.

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely caused by aspiration pneumonia, post-obstructive pneumonia, or a hepatobiliary source. Aggressive fluid repletion and antibiotics are necessary to treat this condition.
2. Hypotension: The patient's hypotension is likely caused by sepsis, hypovolemia, or adrenal insufficiency. Aggressive fluid repletion and vasopressors are necessary to treat this condition.
3. Acute Kidney Injury: The patient's AKI is likely caused by sepsis, hypovolemia, or nephrotoxic medications. Aggressive fluid repletion and vasopressors are necessary to treat this condition.
4. Liver Dysfunction: The patient's liver dysfunction is likely caused by metastatic disease or sepsis. Aggressive fluid repletion and antibiotics are necessary to treat this condition.
5. Respiratory Failure: The patient's respiratory failure is likely caused by sepsis, pneumonia, or respiratory muscle weakness. Mechanical ventilation and aggressive fluid repletion are necessary to treat this condition.
6. Anemia: The patient's anemia is likely caused by chronic GI blood loss, malignancy, or iron deficiency. Blood transfusions and iron supplements may be necessary to treat this condition.
7. Metabolic Acidosis: The patient's metabolic acidosis is likely caused by lactic acidosis, accumulation of organic anions in AKI, or aggressive NS volume expansion. Aggressive fluid repletion and vasopressors are necessary to treat this condition.
8. Asymmetrical LE Edema: The patient's asymmetrical LE edema is likely caused by DVT or PE. Duplex US and TTE are necessary to diagnose and treat this condition.
9. Abnormal LFTs: The patient's abnormal LFTs are likely caused by metastatic disease, sepsis, or cholestatic liver disease. Contrast CT and liver function tests are necessary to diagnose and treat this condition.
10. Dysphagia: The patient's dysphagia is likely caused by esophageal CA or lung CA with extrinsic esophageal compression. EGD and speech/swallow C/S are necessary to diagnose and treat this condition.

Overall, the patient is at high risk for multiple medical complications, including sepsis, hypotension, AKI, liver dysfunction, respiratory failure, anemia, metabolic acidosis, asymmetrical LE edema, abnormal LFTs, and dysphagia. Aggressive fluid repletion, antibiotics, vasopressors, and mechanical ventilation are necessary to treat these conditions."
182947.0,210248,2182-08-24 08:07:00,Physician ,Physician Resident Progress Note,"Chief Complaint: unstable angina, PNA
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   24 Hour Events:
 EKG - At [**2182-8-23**] 08:50 AM
 CHEST PAIN - At [**2182-8-23**] 08:50 AM
   nitroglycerin, aspirin, morphine given. ekg done
 EKG - At [**2182-8-23**] 10:45 AM
   patient was chest pain free EKG obtained [**Name8 (MD) 77**] MD orders.
 VENOGRAM - At [**2182-8-23**] 10:56 AM
   lower extremity dopplers
 TRANSTHORACIC ECHO - At [**2182-8-23**] 11:15 AM
 ARTERIAL LINE - START [**2182-8-23**] 08:04 PM
 EKG - At [**2182-8-23**] 11:05 PM
   c/o cp substernal [**1-22**] given 2mg morphine and ntg x2, lopressor 5mg iv
   ekg showing t wave inversion of lateral leads 111, v4-5
 CHEST PAIN - At [**2182-8-23**] 11:16 PM
   c/o of [**1-22**] cp ekg showing t wave inversion l-v4-5 given morphine 2mg
   iv, lopressor 5mg (tachycardic 118 ST) ntg sl x3 post cp ekg changes
   resolved. During event svo2 dropped to 65% o2 sat 89% placed on
   nonrebreather with improvement in both parameters to 70% and 100%
   SUBJECTIVE:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-24**] 05:04 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Heparin Sodium - [**2182-8-23**] 11:00 AM
   Morphine Sulfate - [**2182-8-23**] 06:30 PM
   Metoprolol - [**2182-8-23**] 10:56 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-24**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.8
C (96.5
   Tcurrent: 35.6
C (96
   HR: 103 (89 - 108) bpm
   BP: 133/54(67) {99/45(59) - 133/57(72)} mmHg
   RR: 18 (16 - 23) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 70 Inch
    CVP: 6 (2 - 11)mmHg
   Mixed Venous O2% Sat: 66 - 66
   Total In:
                                                                 11,914 mL
                                                                  1,275 mL
   PO:
   TF:
   IVF:
                                                                 11,914 mL
                                                                  1,275 mL
   Blood products:
   Total out:
                                                                  1,233 mL
                                                                    425 mL
   Urine:
                                                                  1,233 mL
                                                                    425 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 10,681 mL
                                                                    850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.33/28/58/14/-9
   Physical Examination
   Gen:
   Lungs:
   CV:
   ABD:
   Ext:
   Labs / Radiology
   245 K/uL
   10.1 g/dL
   137 mg/dL
   2.5 mg/dL
   14 mEq/L
   4.0 mEq/L
   73 mg/dL
   115 mEq/L
   142 mEq/L
   30.2 %
   19.5 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
   WBC
   14.7
   15.8
   19.5
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   Plt
   [**Telephone/Fax (3) 145**]
   Cr
   3.0
   2.8
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   Other labs: PT / PTT / INR:16.8/93.3/1.5,
   CK / CKMB / Troponin-T:255/7/0.01,
    ALT / AST:90/260, Alk Phos / T Bili:735/2.5, Amylase / Lipase:155/284,
    Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %,
   Eos:0.1 %,
    Lactic Acid:1.3 mmol/L, Albumin:2.1 g/dL, LDH:495 IU/L,
    Ca++:7.8 mg/dL, Mg++:2.3 mg/dL, PO4:4.6 mg/dL
    Lactate:1.3
   Vanco: 19.4
   Imaging: LE U/S - [**2182-8-24**] -No evidence of lower extremity DVT
   bilaterally.
   ECHO [**2182-8-24**]
   Conclusions
   The left atrium is moderately dilated. The right atrium is moderately
   dilated. No atrial septal defect is seen by 2D or color Doppler. There
   is mild symmetric left ventricular hypertrophy with normal cavity size
   and regional/global systolic function (LVEF>55%). The estimated cardiac
   index is normal (>=2.5L/min/m2). Right ventricular chamber size and
   free wall motion are normal. The aortic valve leaflets (3) are mildly
   thickened but aortic stenosis is not present. There are filamentous
   strands on the aortic leaflets consistent with Lambl's excresences
   (normal variant). Trace aortic regurgitation is seen. The mitral valve
   leaflets are mildly thickened. There is no mitral valve prolapse. Mild
   (1+) mitral regurgitation is seen. The tricuspid valve leaflets are
   mildly thickened. There is mild pulmonary artery systolic hypertension.
   There is no pericardial effusion.
   IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved
   global and regional biventricular systolic function. Mild pulmonary
   hypertension.
   CXR [**2182-8-24**]
   New opacification of L lung to mid-upper lung zones.
   Microbiology: Blood cx NGTD x2
   urine cx NGTD
   leg urine antigen neg.
   ECG: EKGs
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Day/Year 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   -500 cc LR boluses q30 min to achieve CVP >[**9-24**], MAP > 65; consider
   starting levophed if MAP still inadequate
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**3-28**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**3-28**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**2-16**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch when more stable
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -TTE to eval. for FWA, PA pressures, RH strain, baseline LV fxn; kidney
   fxn likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require warrant more attention;
   foley in place, draining so low c/f obstruction
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO in case a procedure required
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line to be placed
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: unstable angina, PNA
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   24 Hour Events:
 EKG - At [**2182-8-23**] 08:50 AM
 CHEST PAIN - At [**2182-8-23**] 08:50 AM
   nitroglycerin, aspirin, morphine given. ekg done
 EKG - At [**2182-8-23**] 10:45 AM
   patient was chest pain free EKG obtained [**Name8 (MD) 77**] MD orders.
 VENOGRAM - At [**2182-8-23**] 10:56 AM
   lower extremity dopplers
 TRANSTHORACIC ECHO - At [**2182-8-23**] 11:15 AM
 ARTERIAL LINE - START [**2182-8-23**] 08:04 PM
 EKG - At [**2182-8-23**] 11:05 PM
   c/o cp substernal [**1-22**] given 2mg morphine and ntg x2, lopressor 5mg iv
   ekg showing t wave inversion of lateral leads 111, v4-5
 CHEST PAIN - At [**2182-8-23**] 11:16 PM
   c/o of [**1-22**] cp ekg showing t wave inversion l-v4-5 given morphine 2mg
   iv, lopressor 5mg (tachycardic 118 ST) ntg sl x3 post cp ekg changes
   resolved. During event svo2 dropped to 65% o2 sat 89% placed on
   nonrebreather with improvement in both parameters to 70% and 100%
   SUBJECTIVE:
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-24**] 05:04 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Heparin Sodium - [**2182-8-23**] 11:00 AM
   Morphine Sulfate - [**2182-8-23**] 06:30 PM
   Metoprolol - [**2182-8-23**] 10:56 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-24**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.8
C (96.5
   Tcurrent: 35.6
C (96
   HR: 103 (89 - 108) bpm
   BP: 133/54(67) {99/45(59) - 133/57(72)} mmHg
   RR: 18 (16 - 23) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 70 Inch
    CVP: 6 (2 - 11)mmHg
   Mixed Venous O2% Sat: 66 - 66
   Total In:
                                                                 11,914 mL
                                                                  1,275 mL
   PO:
   TF:
   IVF:
                                                                 11,914 mL
                                                                  1,275 mL
   Blood products:
   Total out:
                                                                  1,233 mL
                                                                    425 mL
   Urine:
                                                                  1,233 mL
                                                                    425 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 10,681 mL
                                                                    850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.33/28/58/14/-9
   Physical Examination
   Gen:
   Lungs:
   CV:
   ABD:
   Ext:
   Labs / Radiology
   245 K/uL
   10.1 g/dL
   137 mg/dL
   2.5 mg/dL
   14 mEq/L
   4.0 mEq/L
   73 mg/dL
   115 mEq/L
   142 mEq/L
   30.2 %
   19.5 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
   WBC
   14.7
   15.8
   19.5
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   Plt
   [**Telephone/Fax (3) 145**]
   Cr
   3.0
   2.8
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   Other labs: PT / PTT / INR:16.8/93.3/1.5,
   CK / CKMB / Troponin-T:255/7/0.01,
    ALT / AST:90/260, Alk Phos / T Bili:735/2.5, Amylase / Lipase:155/284,
    Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %,
   Eos:0.1 %,
    Lactic Acid:1.3 mmol/L, Albumin:2.1 g/dL, LDH:495 IU/L,
    Ca++:7.8 mg/dL, Mg++:2.3 mg/dL, PO4:4.6 mg/dL
    Lactate:1.3
   Vanco: 19.4
   Imaging: LE U/S - [**2182-8-24**] -No evidence of lower extremity DVT
   bilaterally.
   ECHO [**2182-8-24**]
   Conclusions
   The left atrium is moderately dilated. The right atrium is moderately
   dilated. No atrial septal defect is seen by 2D or color Doppler. There
   is mild symmetric left ventricular hypertrophy with normal cavity size
   and regional/global systolic function (LVEF>55%). The estimated cardiac
   index is normal (>=2.5L/min/m2). Right ventricular chamber size and
   free wall motion are normal. The aortic valve leaflets (3) are mildly
   thickened but aortic stenosis is not present. There are filamentous
   strands on the aortic leaflets consistent with Lambl's excresences
   (normal variant). Trace aortic regurgitation is seen. The mitral valve
   leaflets are mildly thickened. There is no mitral valve prolapse. Mild
   (1+) mitral regurgitation is seen. The tricuspid valve leaflets are
   mildly thickened. There is mild pulmonary artery systolic hypertension.
   There is no pericardial effusion.
   IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved
   global and regional biventricular systolic function. Mild pulmonary
   hypertension.
   CXR [**2182-8-24**]
   New opacification of L lung to mid-upper lung zones.
   Microbiology: Blood cx NGTD x2
   urine cx NGTD
   leg urine antigen neg.
   ECG: EKGs
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Day/Year 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   -500 cc LR boluses q30 min to achieve CVP >[**9-24**], MAP > 65; consider
   starting levophed if MAP still inadequate
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**3-28**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**3-28**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**2-16**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch when more stable
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
   -TTE to eval. for FWA, PA pressures, RH strain, baseline LV fxn; kidney
   fxn likely will not permit CTA to r/o PE
   -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #Gap metabolic acidosis - Lactic acidosis (trending down) vs.
   accumulation of organic anions in ARF; likely contribution from
   aggressive NS volume expansion
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require warrant more attention;
   foley in place, draining so low c/f obstruction
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S to r/o DVT
   -TTE to eval for evidence of PE
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO in case a procedure required
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line to be placed
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease, and metastatic cancer to the liver. He was admitted to the ICU with unstable angina, sepsis, and hypotension. The patient's chest pain is atypical and has been treated with nitroglycerin, aspirin, and morphine. He has also been given heparin and metoprolol. The patient's laboratory results show elevated troponin levels, indicating cardiac injury, and abnormal liver function tests, suggesting liver metastasis. The patient's radiology reports show moderate left atrial dilation, mild symmetric left ventricular hypertrophy, and mild pulmonary hypertension.

Potential Medical Complications:

1. Cardiac Complications:
	* Unstable angina may progress to myocardial infarction (MI) or cardiac arrest.
	* Cardiac tamponade or pericardial effusion may occur due to metastatic disease.
	* Cardiogenic shock may develop due to cardiac failure or arrhythmias.
2. Respiratory Complications:
	* Pneumonia may worsen due to sepsis and lung metastasis.
	* Respiratory failure may occur due to pulmonary hypertension or cardiac failure.
	* Ventilator-associated pneumonia (VAP) is a risk due to prolonged mechanical ventilation.
3. Sepsis Complications:
	* Sepsis may progress to septic shock or multi-organ failure.
	* Infections may spread to other sites, such as the bloodstream or urinary tract.
4. Liver Complications:
	* Liver metastasis may worsen, leading to liver failure or cirrhosis.
	* Cholestasis may occur due to liver metastasis or sepsis.
5. Renal Complications:
	* Acute kidney injury (AKI) may worsen due to sepsis, hypovolemia, or nephrotoxic medications.
	* Chronic kidney disease (CKD) may progress due to underlying disease or medications.
6. Hematological Complications:
	* Anemia may worsen due to chronic blood loss or bone marrow suppression.
	* Thrombocytopenia may occur due to sepsis, liver disease, or medications.
7. Neurological Complications:
	* Cerebral edema or hemorrhage may occur due to sepsis, hypoxia, or cardiac failure.
	* Neurological deficits may develop due to cerebral vasospasm or stroke.

Given the patient's complex medical condition, it is essential to monitor him closely for any signs of complications and adjust his treatment plan accordingly."
182947.0,210248,2182-08-24 08:07:00,Physician ,Physician Resident Progress Note,"Chief Complaint: unstable angina, PNA
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   24 Hour Events:
 CHEST PAIN - At [**2182-8-23**] 08:50 AM
   nitroglycerin, aspirin, morphine given. ekg showed t-wave inversions in
   v4-6 and inferior leads.
 EKG - At [**2182-8-23**] 10:45 AM
 repeat EKG down when patient was chest
   pain free showed resolution of TW inversion in V4-6.
 VENOGRAM - At [**2182-8-23**] 10:56 AM
   lower extremity dopplers
 TRANSTHORACIC ECHO - At [**2182-8-23**] 11:15 AM
 ARTERIAL LINE - START [**2182-8-23**] 08:04 PM
 CHEST PAIN - At [**2182-8-23**] 11:16 PM
   c/o of [**1-22**] cp
 patient was given morphine 2mg iv, lopressor 5mg
   (tachycardic 118 ST) ntg sl x3 post cp ekg changes resolved. During
   event svo2 dropped to 65% o2 sat 89% placed on nonrebreather with
   improvement in both parameters to 70% and 100%
 EKG - At [**2182-8-23**] 11:05 PM
 shows [**Street Address(2) 146**] depression in V4-5 and
   possibly V6.   TW inversion in inferior/lateral leads.
 trying to keep CVP between [**9-24**]
 not very fluid responsive anymore.
   UOP good.
 ABG done because of low HCO3.  O2 Sats in low 90s on 3 L but b/c of
   ABG increased to 5L NC.
   SUBJECTIVE:   Denies SOB, CP since last night.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-24**] 05:04 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Heparin Sodium - [**2182-8-23**] 11:00 AM
   Morphine Sulfate - [**2182-8-23**] 06:30 PM
   Metoprolol - [**2182-8-23**] 10:56 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-24**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.8
C (96.5
   Tcurrent: 35.6
C (96
   HR: 103 (89 - 108) bpm
   BP: 133/54(67) {99/45(59) - 133/57(72)} mmHg
   RR: 18 (16 - 23) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 70 Inch
    CVP: 6 (2 - 11)mmHg
   Mixed Venous O2% Sat: 66 - 66
   Total In:
                                                                 11,914 mL
                                                                  1,275 mL
   PO:
   TF:
   IVF:
                                                                 11,914 mL
                                                                  1,275 mL
   Blood products:
   Total out:
                                                                  1,233 mL
                                                                    425 mL
   Urine:
                                                                  1,233 mL
                                                                    425 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 10,681 mL
                                                                    850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.33/28/58/14/-9
   Physical Examination
   Gen: Patient has baseline dysarthria and right sided hemiparesis.  A&O
   x3, NAD
   Lungs: decreased breath sounds at left base, no crackles
   CV: rapid rate, regular rhythm, s1 & S2nl, no m/r/g
   ABD: +bs, soft, non-tender, non-distended
   Ext: warm, dry, 2 + radial pulses.
   Labs / Radiology
   245 K/uL
   10.1 g/dL
   137 mg/dL
   2.5 mg/dL
   14 mEq/L
   4.0 mEq/L
   73 mg/dL
   115 mEq/L
   142 mEq/L
   30.2 %
   19.5 K/uL
        [image002.jpg]
   AG = 13
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
   WBC
   14.7
   15.8
   19.5
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   Plt
   [**Telephone/Fax (3) 145**]
   Cr
   3.0
   2.8
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   Other labs: PT / PTT / INR:16.8/93.3/1.5,
   CK / CKMB / Troponin-T:255/7/0.01
   (note cardiac enzymes cycled x3 overnight, most recent set above, CK
   steadily declining.  No increase in troponins)
    ALT / AST:90/260, Alk Phos / T Bili:735/2.5, Amylase / Lipase:155/284,
    Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %,
   Eos:0.1 %,
    Lactic Acid:1.3 mmol/L, Albumin:2.1 g/dL, LDH:495 IU/L,
    Ca++:7.8 mg/dL, Mg++:2.3 mg/dL, PO4:4.6 mg/dL
    Lactate:1.3
   Vanco: 19.4
   Imaging: LE U/S - [**2182-8-24**] -No evidence of lower extremity DVT
   bilaterally.
   ECHO [**2182-8-24**]
   Conclusions
   The left atrium is moderately dilated. The right atrium is moderately
   dilated. No atrial septal defect is seen by 2D or color Doppler. There
   is mild symmetric left ventricular hypertrophy with normal cavity size
   and regional/global systolic function (LVEF>55%). The estimated cardiac
   index is normal (>=2.5L/min/m2). Right ventricular chamber size and
   free wall motion are normal. The aortic valve leaflets (3) are mildly
   thickened but aortic stenosis is not present. There are filamentous
   strands on the aortic leaflets consistent with Lambl's excresences
   (normal variant). Trace aortic regurgitation is seen. The mitral valve
   leaflets are mildly thickened. There is no mitral valve prolapse. Mild
   (1+) mitral regurgitation is seen. The tricuspid valve leaflets are
   mildly thickened. There is mild pulmonary artery systolic hypertension.
   There is no pericardial effusion.
   IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved
   global and regional biventricular systolic function. Mild pulmonary
   hypertension.
   CXR [**2182-8-24**]
   New opacification of L lung to mid-upper lung zones.
   Microbiology: Blood cx NGTD x2
   urine cx NGTD
   leg urine antigen neg.
   ECG:  see 24 hr events for description of EKGs.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Day/Year 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**4-26**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**4-26**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**3-19**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: unstable angina, PNA
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   24 Hour Events:
 CHEST PAIN - At [**2182-8-23**] 08:50 AM
   nitroglycerin, aspirin, morphine given. ekg showed t-wave inversions in
   v4-6 and inferior leads.
 EKG - At [**2182-8-23**] 10:45 AM
 repeat EKG down when patient was chest
   pain free showed resolution of TW inversion in V4-6.
 VENOGRAM - At [**2182-8-23**] 10:56 AM
   lower extremity dopplers
 TRANSTHORACIC ECHO - At [**2182-8-23**] 11:15 AM
 ARTERIAL LINE - START [**2182-8-23**] 08:04 PM
 CHEST PAIN - At [**2182-8-23**] 11:16 PM
   c/o of [**1-22**] cp
 patient was given morphine 2mg iv, lopressor 5mg
   (tachycardic 118 ST) ntg sl x3 post cp ekg changes resolved. During
   event svo2 dropped to 65% o2 sat 89% placed on nonrebreather with
   improvement in both parameters to 70% and 100%
 EKG - At [**2182-8-23**] 11:05 PM
 shows [**Street Address(2) 146**] depression in V4-5 and
   possibly V6.   TW inversion in inferior/lateral leads.
 trying to keep CVP between [**9-24**]
 not very fluid responsive anymore.
   UOP good.
 ABG done because of low HCO3.  O2 Sats in low 90s on 3 L but b/c of
   ABG increased to 5L NC.
   SUBJECTIVE:   Denies SOB, CP since last night.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-24**] 05:04 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Heparin Sodium - [**2182-8-23**] 11:00 AM
   Morphine Sulfate - [**2182-8-23**] 06:30 PM
   Metoprolol - [**2182-8-23**] 10:56 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-24**] 07:47 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 35.8
C (96.5
   Tcurrent: 35.6
C (96
   HR: 103 (89 - 108) bpm
   BP: 133/54(67) {99/45(59) - 133/57(72)} mmHg
   RR: 18 (16 - 23) insp/min
   SpO2: 96%
   Heart rhythm: SR (Sinus Rhythm)
   Height: 70 Inch
    CVP: 6 (2 - 11)mmHg
   Mixed Venous O2% Sat: 66 - 66
   Total In:
                                                                 11,914 mL
                                                                  1,275 mL
   PO:
   TF:
   IVF:
                                                                 11,914 mL
                                                                  1,275 mL
   Blood products:
   Total out:
                                                                  1,233 mL
                                                                    425 mL
   Urine:
                                                                  1,233 mL
                                                                    425 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                 10,681 mL
                                                                    850 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 96%
   ABG: 7.33/28/58/14/-9
   Physical Examination
   Gen: Patient has baseline dysarthria and right sided hemiparesis.  A&O
   x3, NAD
   Lungs: decreased breath sounds at left base, no crackles
   CV: rapid rate, regular rhythm, s1 & S2nl, no m/r/g
   ABD: +bs, soft, non-tender, non-distended
   Ext: warm, dry, 2 + radial pulses.
   Labs / Radiology
   245 K/uL
   10.1 g/dL
   137 mg/dL
   2.5 mg/dL
   14 mEq/L
   4.0 mEq/L
   73 mg/dL
   115 mEq/L
   142 mEq/L
   30.2 %
   19.5 K/uL
        [image002.jpg]
   AG = 13
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
   WBC
   14.7
   15.8
   19.5
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   Plt
   [**Telephone/Fax (3) 145**]
   Cr
   3.0
   2.8
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   Other labs: PT / PTT / INR:16.8/93.3/1.5,
   CK / CKMB / Troponin-T:255/7/0.01
   (note cardiac enzymes cycled x3 overnight, most recent set above, CK
   steadily declining.  No increase in troponins)
    ALT / AST:90/260, Alk Phos / T Bili:735/2.5, Amylase / Lipase:155/284,
    Differential-Neuts:88.0 %, Band:0.0 %, Lymph:5.3 %, Mono:6.6 %,
   Eos:0.1 %,
    Lactic Acid:1.3 mmol/L, Albumin:2.1 g/dL, LDH:495 IU/L,
    Ca++:7.8 mg/dL, Mg++:2.3 mg/dL, PO4:4.6 mg/dL
    Lactate:1.3
   Vanco: 19.4
   Imaging: LE U/S - [**2182-8-24**] -No evidence of lower extremity DVT
   bilaterally.
   ECHO [**2182-8-24**]
   Conclusions
   The left atrium is moderately dilated. The right atrium is moderately
   dilated. No atrial septal defect is seen by 2D or color Doppler. There
   is mild symmetric left ventricular hypertrophy with normal cavity size
   and regional/global systolic function (LVEF>55%). The estimated cardiac
   index is normal (>=2.5L/min/m2). Right ventricular chamber size and
   free wall motion are normal. The aortic valve leaflets (3) are mildly
   thickened but aortic stenosis is not present. There are filamentous
   strands on the aortic leaflets consistent with Lambl's excresences
   (normal variant). Trace aortic regurgitation is seen. The mitral valve
   leaflets are mildly thickened. There is no mitral valve prolapse. Mild
   (1+) mitral regurgitation is seen. The tricuspid valve leaflets are
   mildly thickened. There is mild pulmonary artery systolic hypertension.
   There is no pericardial effusion.
   IMPRESSION: Mild symmetric left ventricular hypertrophy with preserved
   global and regional biventricular systolic function. Mild pulmonary
   hypertension.
   CXR [**2182-8-24**]
   New opacification of L lung to mid-upper lung zones.
   Microbiology: Blood cx NGTD x2
   urine cx NGTD
   leg urine antigen neg.
   ECG:  see 24 hr events for description of EKGs.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Month/Day/Year 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**4-26**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**4-26**]) , recheck trough prior to 3rd dose
   -add azithromycin (day [**3-19**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, the patient is an 80-year-old male with a history of CAD, CVA, HTN, COPD, and CA metastatic to the liver, currently admitted to the ICU for unstable angina, sepsis, and hypotension.

The patient's current medical conditions include:

1. Unstable angina: The patient is experiencing recurrent episodes of chest pain, which are likely related to cardiac ischemia.
2. Sepsis: The patient has a high suspicion of sepsis, likely due to aspiration pneumonia, post-obstructive pneumonia, or a primary lung CA.
3. Hypotension: The patient's blood pressure is low, which may be due to hypovolemia, sepsis, or adrenal insufficiency.
4. Anemia: The patient has a low hemoglobin level, which may be due to chronic GI blood loss, malignancy, or Fe-deficiency.
5. Metabolic acidosis: The patient has a metabolic acidosis, likely due to fluid resuscitation with NS.
6. ARF: The patient has acute renal failure, which may be due to pre-renal azotemia, ATN, or post-renal azotemia.
7. Abnormal LFT's: The patient has abnormal liver function tests, which may be due to diffuse metastatic disease, intrahepatic cholestasis, or biliary obstruction.
8. Dysphagia: The patient has a high risk of aspiration due to esophageal CA or lung CA with extrinsic esophageal compression.
9. COPD: The patient has chronic obstructive pulmonary disease, which is currently stable.
10. HTN: The patient has hypertension, which is currently being held due to low blood pressure.
11. Hyperlipidemia: The patient has hyperlipidemia, which is currently being held due to elevated LFT's.
12. Chronic back pain: The patient has chronic back pain, which is being managed with lidocaine patches.

Potential medical complications that can arise include:

1. Cardiac complications: The patient's unstable angina and low blood pressure may lead to cardiac complications such as cardiogenic shock, arrhythmias, or cardiac arrest.
2. Respiratory complications: The patient's COPD and sepsis may lead to respiratory complications such as acute respiratory distress syndrome (ARDS), pneumonia, or respiratory failure.
3. Renal complications: The patient's ARF may lead to chronic kidney disease, dialysis dependence, or end-stage renal disease.
4. Gastrointestinal complications: The patient's anemia, dysphagia, and chronic back pain may lead to gastrointestinal complications such as bleeding, perforation, or obstruction.
5. Infections: The patient's sepsis and immunosuppression may lead to infections such as pneumonia, urinary tract infections, or bloodstream infections.
6. Liver complications: The patient's abnormal LFT's may lead to liver complications such as liver failure, encephalopathy, or bleeding.
7. Cardiovascular complications: The patient's hypertension, hyperlipidemia, and CAD may lead to cardiovascular complications such as myocardial infarction, heart failure, or stroke.

The patient requires close monitoring and management of his medical conditions to prevent or minimize these potential complications."
182947.0,210248,2182-08-25 07:18:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
   c/o
gas pains
 in chest; VSS, EKG did not show any ST-T wave changes;
   pain relieved with maalox
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history: pt
s son recently passed away
   from liver disease related to ETOH use
   Review of systems is unchanged from admission except as noted below
   Review of systems: c/o constant diffuse
gas pain
 [**3-24**] beginning R
   abdomen and radiating throughout body; no crushing CP, SOB, N/V
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Telephone/Fax (3) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**5-27**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**5-27**]) , recheck trough on AM [**8-26**]
   -add azithromycin (day [**4-17**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
   c/o
gas pains
 in chest; VSS, EKG did not show any ST-T wave changes;
   pain relieved with maalox
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history: pt
s son recently passed away
   from liver disease related to ETOH use
   Review of systems is unchanged from admission except as noted below
   Review of systems: c/o constant diffuse
gas pain
 [**3-24**] beginning R
   abdomen and radiating throughout body; no crushing CP, SOB, N/V
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Telephone/Fax (3) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**5-27**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**5-27**]) , recheck trough on AM [**8-26**]
   -add azithromycin (day [**4-17**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and liver metastasis from an unknown primary site. The patient is currently admitted to the ICU for atypical chest pain, sepsis, and hypotension.

The patient's vital signs are stable, with a temperature of 36.1°C, heart rate of 113 bpm, blood pressure of 133/54 mmHg, and respiratory rate of 21 breaths per minute. The patient's oxygen saturation is 100% on a face tent.

The patient has a history of liver disease related to ethanol use, which may be a contributing factor to his current condition.

The patient's laboratory results show:

* White blood cell count (WBC): 14.7-21.8 x 10^9/L
* Hematocrit (Hct): 30.4-31.6%
* Platelet count (Plt): 26-148 x 10^9/L
* Creatinine (Cr): 2.5-3.0 mg/dL
* Troponin-T: <0.01-0.01 ng/mL
* Lactic acid: 1.3 mmol/L
* Albumin: 2.1 g/dL
* LDH: 495 IU/L
* Calcium: 8.0 mg/dL
* Magnesium: 2.5 mg/dL
* Phosphorus: 4.9 mg/dL

The patient's medical conditions include:

* Acute coronary syndrome (ACS)
* Sepsis
* Hypotension
* Anemia
* Metabolic acidosis
* Acute kidney injury (ARF)
* Asymmetrical leg edema
* Abnormal liver function tests (LFTs)
* Dysphagia
* Chronic obstructive pulmonary disease (COPD)
* Hypertension
* Hyperlipidemia
* Chronic back pain

The patient's plan of care includes:

* Oxygen therapy
* Morphine and nitroglycerin for pain management
* Heparin infusion for ACS and prophylaxis against deep vein thrombosis (DVT)
* PPI for stress ulcer prophylaxis
* Insulin sliding scale for glycemic control
* Prophylactic antibiotics for sepsis
* Fluid resuscitation and vasopressor support for hypotension
* Monitoring of vital signs, laboratory results, and respiratory status
* Consideration of diagnostic bronchoscopy and esophagogastroduodenoscopy (EGD) when clinically stable

Potential medical complications that may arise include:

* Cardiac arrest due to ACS or sepsis
* Respiratory failure due to sepsis or COPD
* Renal failure due to ARF or sepsis
* Hepatic failure due to liver metastasis or sepsis
* Gastrointestinal bleeding due to dysphagia or liver disease
* Infection due to sepsis or aspiration
* Thromboembolic events due to DVT or pulmonary embolism
* Fluid overload due to excessive fluid administration
* Hypoglycemia due to insulin therapy
* Hypotension due to sepsis or vasopressor withdrawal."
182947.0,210248,2182-08-25 07:18:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Sepsis
   24 Hour Events:
   c/o
gas pains
 in chest; VSS, EKG did not show any ST-T wave changes;
   pain relieved with maalox
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history: pt
s son recently passed away
   from liver disease related to ETOH use
   Review of systems is unchanged from admission except as noted below
   Review of systems: c/o constant diffuse
gas pain
 [**3-24**] beginning R
   abdomen and radiating throughout body; no crushing CP, SOB, N/V
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   GEN: awake, A&Ox3, NAD, b/l dysarthria, face tent in place
   CV: reg tachy nl S1S2 no m/r/g
   PULM: decreased breath sounds at L>R base, no w/r/r
   ABD: soft, NTND +BS tender HM
   EXT: warm, dry, +PP 1+ pitting edema bilat
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: TF
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   24 Hour Events:
   c/o
gas pains
 in chest; VSS, EKG did not show any ST-T wave changes;
   pain relieved with maalox
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history: pt
s son recently passed away
   from liver disease related to ETOH use
   Review of systems is unchanged from admission except as noted below
   Review of systems: c/o constant diffuse
gas pain
 [**3-24**] beginning R
   abdomen and radiating throughout body; no crushing CP, SOB, N/V
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   GEN: awake, A&Ox3, NAD, b/l dysarthria, face tent in place
   CV: reg tachy nl S1S2 no m/r/g
   PULM: decreased breath sounds at L>R base, no w/r/r
   ABD: soft, NTND +BS tender HM
   EXT: warm, dry, +PP 1+ pitting edema bilat
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition: TF
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a complex medical history, including coronary artery disease, cerebral vascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and a recent diagnosis of metastatic liver cancer. The patient is currently in the intensive care unit (ICU) due to sepsis, hypotension, and respiratory failure.

The patient's current condition is as follows:

* Respiratory: The patient is receiving oxygen therapy via a face tent and has a SpO2 of 100%. The arterial blood gas (ABG) results show a pH of 7.33, pCO2 of 28, and pO2 of 58. The patient has decreased breath sounds at the left base and no wheezing or rhonchi.
* Cardiovascular: The patient has a heart rate of 113 beats per minute, blood pressure of 133/54 mmHg, and a central venous pressure (CVP) of 6 mmHg. The patient has a history of coronary artery disease and has undergone coronary artery bypass grafting (CABG).
* Renal: The patient has acute kidney injury (AKI) with a blood urea nitrogen (BUN) level of 226 mg/dL and a creatinine level of 2.6 mg/dL. The patient has a BUN-to-creatinine ratio of 86, which suggests pre-renal azotemia.
* Hepatic: The patient has abnormal liver function tests (LFTs) with elevated alkaline phosphatase, aspartate transaminase (AST), and bilirubin levels. The patient has a history of liver disease related to ethanol use.
* Metabolic: The patient has a metabolic acidosis with a pH of 7.33 and a base excess of -9 mmol/L. The patient has a high anion gap metabolic acidosis, which is likely due to the patient's underlying liver disease and AKI.
* Gastrointestinal: The patient has a history of dysphagia and is at high risk for aspiration. The patient has a hiatal hernia and is receiving proton pump inhibitor (PPI) therapy.
* Infectious: The patient has sepsis, which is likely related to aspiration pneumonia. The patient has a positive blood culture and is receiving vancomycin and piperacillin-tazobactam antibiotics.
* Neurological: The patient has a history of cerebral vascular accident and is at risk for brain metastases.

Potential medical complications that may arise include:

* Respiratory failure: The patient's respiratory status is critical, and the patient may require mechanical ventilation.
* Cardiac arrest: The patient's cardiac status is unstable, and the patient may be at risk for cardiac arrest.
* Sepsis-related organ dysfunction: The patient's sepsis may lead to organ dysfunction, including acute kidney injury, liver dysfunction, and cardiovascular instability.
* Aspiration pneumonia: The patient's risk for aspiration pneumonia is high, and the patient may require aggressive respiratory support and antibiotics.
* Metastatic disease: The patient's metastatic liver cancer may lead to further complications, including liver failure, bleeding, and pain.
* Infections: The patient is at risk for infections, including pneumonia, urinary tract infections, and central line-associated bloodstream infections.

The patient's current treatment plan includes:

* Antibiotics for sepsis
* Heparin therapy for deep vein thrombosis prophylaxis
* PPI therapy for stress ulcer prophylaxis
* Prophylactic anticoagulation with warfarin
* Incentive spirometry for respiratory therapy
* Regular insulin sliding scale for glycemic control
* Continuous renal replacement therapy (CRRT) for AKI
* Liver function tests (LFTs) and bilirubin levels will be monitored regularly
* Repeat urine lytes, sediment, and renal ultrasound will be performed as needed
* Contrast computed tomography (CT) or magnetic resonance cholangiopancreatography (MRCP) will be performed when clinically stable
* Head CT will be performed if the patient requires additional systemic anticoagulation."
182947.0,210248,2182-08-25 07:18:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-24**] 09:00 PM
   nitro SL x3
 EKG - At [**2182-8-24**] 09:45 PM
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Telephone/Fax (3) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**5-27**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**5-27**]) , recheck trough on AM [**8-26**]
   -add azithromycin (day [**4-17**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-24**] 09:00 PM
   nitro SL x3
 EKG - At [**2182-8-24**] 09:45 PM
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   History obtained from [**Hospital 19**] Medical recordsNo Known Drug Allergies
   Last dose of Antibiotics:
   Vancomycin - [**2182-8-23**] 12:15 PM
   Piperacillin - [**2182-8-25**] 03:08 AM
   Infusions:
   Heparin Sodium - 850 units/hour
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-25**] 07:18 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.1
C (96.9
   Tcurrent: 35.7
C (96.2
   HR: 113 (99 - 115) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 21 (14 - 29) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 6 (-2 - 11)mmHg
   Total In:
                                                                  2,419 mL
                                                                    434 mL
   PO:
   TF:
   IVF:
                                                                  2,419 mL
                                                                    434 mL
   Blood products:
   Total out:
                                                                  1,645 mL
                                                                    305 mL
   Urine:
                                                                  1,645 mL
                                                                    305 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    774 mL
                                                                    129 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 100%
   ABG: 7.33/28/58/13/-9
   PaO2 / FiO2: 83
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   226 K/uL
   10.6 g/dL
   138 mg/dL
   2.6 mg/dL
   13 mEq/L
   4.0 mEq/L
   83 mg/dL
   114 mEq/L
   143 mEq/L
   31.6 %
   21.8 K/uL
        [image002.jpg]
                             [**2182-8-22**]  10:45 PM
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
   WBC
   14.7
   15.8
   19.5
   21.8
   Hct
   30.4
   28.8
   29.1
   30.4
   30.2
   31.6
   Plt
   [**Telephone/Fax (3) 148**]26
   Cr
   3.0
   2.8
   2.5
   2.5
   2.6
   TropT
   <0.01
   <0.01
   0.01
   TCO2
   14
   15
   Glucose
   176
   155
   173
   137
   138
   Other labs: PT / PTT / INR:16.7/55.0/1.5, CK / CKMB /
   Troponin-T:255/7/0.01, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.3 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.0 mg/dL, Mg++:2.5 mg/dL, PO4:4.9 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #ACS
 new lateral ST-depr. assoc. with atypical chest pain, different
   from pain described on admission, c/w unstable angina more likely than
   demand ischemia; CE
s neg x 2; given O2, morphine, SL nitro, [**Telephone/Fax (3) 119**]
   -morphine, nitro PRN until pain-free f/b repeat EKG
   - consider Nitro gtt if pain returns
   -heparin gtt, goal PTT: 60-80
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -cont. cycle CE
   -start low-dose B-blocker if BP allows
   -telemetry
   -monitor EKG for resolution of ST changes.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff
   - monitor UOP for volume status
 avoid further boluses if possible.
   Give pressors & fluids if needed.
   -place A-line for better BP monitoring
   -cont. zosyn for G-/anaerobic resp/GI flora (day [**5-27**])
   -rec'd 1 dose vanco @ OSH prior to trough level; restart vanco (day
   [**5-27**]) , recheck trough on AM [**8-26**]
   -add azithromycin (day [**4-17**]) for cov
g atypical resp organisms
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch if patient requires intubation.
   -aspiration precautions
   #Hypotension - DDx incl. hypovolemia (poor intake, diarrhea, ? GI blood
   loss) vs. sepsis (as above) vs. adrenal insufficiency (was recently
   started on steroid taper) ; less likely are cardiogenic shock (low CVP,
   no pulm edema, warm & dry extremities, CE
s WNL), PE (mildly hypoxic
   but not tachycardic, no evidence of RH strain on EKG; anticoagulating
   for ACS anyway), pericardial effusion/tamponade (JVP not elevated, no
   distant heart sounds)
   -Treat for sepsis and hypovolemia as above with aggressive fluid
   repletion; monitor UOP closely (goal > 40 cc/hr)
    -AM cortisol difficult to interpret as patient is on steroid therapy
   and received a dose of HC @ OSH ED; will cont. on outpatient dose of
   prednisone 40 mg daily; may require stress-dose steroids if remains
   hypotensive
   #Anemia - no known b/l; low MCV suggests Fe-deficiency likely in the
   setting of malignancy and chronic GI blood loss; may be a component of
   ACD; guaiac +
   -follow clinically & Hct [**Hospital1 **] while on heparin gtt
   -T&C, x-fuse for < 28%
   #metabolic acidosis -  Anion gap closed.  Likely due to fluid
   resusitation with NS.
   -avoid further fluid boluses if possible.
   -ABG suggestive of concomitant respiratory alkalosis
   -LR for volume repletion in light of hyperchloremia
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, ddx includes
   ATN in the setting of hypotension and/or sepsis; microscopic hematuria,
   pyuria and active urinary sediment require more attention; foley in
   place, draining so low c/f obstruction
   -Continue to monitor
   -fluid challenge, BP support as above
   -monitor serum lytes
   -goal UOP > 40 cc/hr
   -dose meds for GFR<20
   #Asymmetical LE edema - calves nontender, nonerythematous, but at high
   risk given malignancy
   -duplex U/S
neg for DVT bilat.
   -systemic anticoagulation for ACS
   #Abnormal LFT's
 Trending down slightly; diffuse metastatic disease (?
   esophageal vs. lung vs. colon primary) by RUQ U/S, but could not
   adequately visualize biliary tree. Low albumin/elevated INR suggest
   diminished synthetic function. Markedly elevated Alk phos/AST with T
   Bili 2X ULN suggests a cholestatic pattern of such as intrahepatic
   cholestasis (i.e. in the setting of sepsis) or biliary obstruction
   (given high amylase/lipase)
   -will pursue contrast CT when clinically more stable, renal fxn
   improved
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   #COPD - no s/sx acute exacerbation
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -prednisone 40 mg daily
   -Inhaled moisturized air for dry mouth
   -Insentive spirometry.
   #HTN
   -holding antihypertensives while BP low
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and at risk for GIB
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP as above,
   UOP > 40 cc/hr
   -NPO due to concern re: swallowing ability
 meds okay to take PO
   -monitor lytes, replete PRN
   #PPx - PPI, heparin gtt
   #Access - R IJ, PIV; art-line
   #Contact - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (unclear if she's HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient)
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: (Systemic anticoagulation: Heparin gtt)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a history of coronary artery disease, chronic obstructive pulmonary disease (COPD), and hypothyroidism, who was admitted to the hospital with atypical chest pain, sepsis, and hypotension.

The patient has a complex medical history, including a recent diagnosis of cancer metastatic to the liver, which may be contributing to his symptoms.

The patient's current condition is characterized by:

1. Chest pain: The patient has reported chest pain, which is associated with lateral ST-depression on the EKG. The pain is not consistent with demand ischemia and is more likely related to unstable angina.
2. Sepsis: The patient has sepsis, which is likely related to aspiration pneumonia, but may also be caused by a primary lung cancer or hepatobiliary source.
3. Hypotension: The patient has hypotension, which may be related to hypovolemia, sepsis, or adrenal insufficiency.
4. Anemia: The patient has anemia, which is likely related to chronic GI blood loss and may be a component of anemia of chronic disease.
5. Metabolic acidosis: The patient has metabolic acidosis, which is likely related to fluid resuscitation with normal saline.
6. Acute kidney injury (ARF): The patient has ARF, which may be related to pre-renal azotemia, ATN, or sepsis.
7. Abnormal liver function tests (LFTs): The patient has abnormal LFTs, which may be related to diffuse metastatic disease or biliary obstruction.
8. Dysphagia: The patient has dysphagia, which may be related to esophageal cancer or lung cancer with extrinsic esophageal compression.
9. COPD: The patient has COPD, which is not currently exacerbating.
10. Hyperlipidemia: The patient has hyperlipidemia, which is being held due to elevated LFTs.

The patient's medical plan includes:

1. Ongoing management of sepsis, including antibiotic therapy and fluid resuscitation.
2. Treatment of unstable angina, including nitroglycerin and morphine.
3. Management of hypotension, including fluid resuscitation and pressor support.
4. Monitoring of liver function tests and potential treatment of biliary obstruction.
5. Management of ARF, including fluid challenge and BP support.
6. Monitoring of electrolytes and repletion as needed.
7. Ongoing management of COPD, including bronchodilators and inhalers.
8. Holding of antihypertensives and hyperlipidemia medications due to elevated LFTs.
9. Management of chronic back pain, including lidocaine patches and avoidance of NSAIDs.
10. Monitoring of glycemic control and potential treatment of hyperglycemia.

The patient's code status is full code, and he is being treated in the intensive care unit (ICU) with ongoing monitoring and management of his complex medical condition."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -restart heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -restart heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and colon cancer with metastases to the liver. He was admitted with atypical chest pain, sepsis, and hypotension. His current condition is characterized by:

* Chest pain syndrome with reversible lateral ST depression, likely due to demand ischemia
* Sepsis, most likely due to aspiration pneumonia, with a negative blood culture
* Gap metabolic acidosis with an ABG showing metabolic acidosis and respiratory alkalosis
* Acute kidney injury (ARF) with a BUN/Cr ratio, low urine sodium, and cellular casts in the sediment
* Abnormal liver function tests (LFTs) with elevated alkaline phosphatase, aspartate aminotransferase, and total bilirubin
* Dysphagia, possibly due to esophageal cancer or lung cancer with extrinsic compression
* COPD with no signs of acute exacerbation
* Hypertension, hyperlipidemia, and chronic back pain

Potential Medical Complications:

1. Sepsis: The patient's sepsis is likely to progress if not adequately treated, leading to organ dysfunction and potentially life-threatening complications.
2. ARF: The patient's acute kidney injury is likely to worsen if not managed promptly, leading to further complications such as electrolyte imbalances, acidosis, and increased risk of mortality.
3. Liver dysfunction: The patient's abnormal LFTs may indicate liver dysfunction, which could lead to further complications such as coagulopathy, bleeding, and increased risk of mortality.
4. Aspiration pneumonia: The patient's aspiration pneumonia may progress if not adequately treated, leading to further respiratory complications and potentially life-threatening outcomes.
5. Metastatic disease: The patient's metastatic colon cancer may progress, leading to further complications and potentially life-threatening outcomes.
6. Cardiac complications: The patient's history of coronary artery disease and demand ischemia may lead to cardiac complications such as arrhythmias, myocardial infarction, and heart failure.
7. Respiratory failure: The patient's COPD and aspiration pneumonia may lead to respiratory failure, which could be life-threatening if not adequately managed.
8. Gastrointestinal complications: The patient's dysphagia and abnormal LFTs may lead to gastrointestinal complications such as bleeding, perforation, and increased risk of mortality."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing tachypneic on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing tachypneic on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's condition as follows:

The patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and previously diagnosed colon cancer with metastasis to the liver. He is currently admitted to the Intensive Care Unit (ICU) with symptoms of atypical chest pain, sepsis, and hypotension.

The patient's vital signs are:

* Temperature: 36.6°C (97.8°F)
* Heart rate: 113 beats per minute (bpm)
* Blood pressure: 133/54 mmHg
* Respiratory rate: 23 breaths per minute (bpm)
* Oxygen saturation: 94%

The patient's laboratory results show:

* White blood cell count: 15.8 x 10^9/L
* Hemoglobin: 9.9 g/dL
* Platelet count: 87 x 10^9/L
* Creatinine: 2.8 mg/dL
* Troponin-T: <0.01 ng/mL
* Lactic acid: 1.9 mmol/L
* Albumin: 2.1 g/dL
* LDH: 495 IU/L
* Calcium: 8.1 mg/dL
* Magnesium: 2.5 mg/dL
* Phosphate: 4.4 mg/dL

The patient's medical conditions and potential complications include:

1. Sepsis: likely caused by aspiration pneumonia or post-obstructive pneumonia from primary lung cancer or hepatobiliary source.
2. Chest pain syndrome: reversible lateral ST-depression associated with atypical chest pain and demand ischemia in the setting of low diastolic blood pressure.
3. Metabolic acidosis: likely caused by ARF, NS expansion acidosis, and resolving lactic acidosis.
4. ARF: with a BUN/Cr ratio, low urine sodium, and cellular casts in sediment, suggesting pre-renal azotemia.
5. Abnormal liver function tests: stable, with diffuse metastatic disease and cholestatic pattern, suggesting intrahepatic cholestasis or biliary obstruction.
6. Dysphagia: likely caused by esophageal cancer or lung cancer with extrinsic esophageal compression.
7. COPD: no acute exacerbation, but with a history of chronic obstructive pulmonary disease.
8. Hypertension: currently being held due to low blood pressure.
9. Hyperlipidemia: holding Crestor due to elevated liver function tests.
10. Chronic back pain: managed with lidocaine patch, with caution due to ARF and elevated liver function tests.

The patient's plan of care includes:

1. Sepsis management: with heparin infusion, antibiotics, and supportive care.
2. Chest pain management: with morphine, nitroglycerin, and telemetry monitoring.
3. Metabolic acidosis management: with fluid repletion, electrolyte correction, and follow-up ABGs.
4. ARF management: with fluid repletion, electrolyte correction, and consideration of repeat urine electrolytes, sediment, and renal ultrasound.
5. Abnormal liver function tests management: with further evaluation and management of liver disease.
6. Dysphagia management: with NG tube placement, aspiration precautions, and consideration of EGD.
7. COPD management: with albuterol nebs, incentive spirometry, and chest PT.
8. Hypertension management: with holding antihypertensives until blood pressure improves.
9. Hyperlipidemia management: with holding Crestor until liver function tests improve.
10. Chronic back pain management: with lidocaine patch and caution due to ARF and elevated liver function tests.

Potential medical complications that can arise include:

1. Sepsis progression: with worsening organ dysfunction and mortality.
2. ARF progression: with worsening kidney function and potential need for dialysis.
3. Metabolic acidosis progression: with worsening acidosis and potential complications such as cardiac arrhythmias and seizures.
4. Liver failure: with worsening liver function and potential need for liver transplantation.
5. Aspiration pneumonia: with worsening respiratory function and potential need for mechanical ventilation.
6. Cardiac arrhythmias: with worsening cardiac function and potential need for cardioversion.
7. Pulmonary embolism: with worsening respiratory function and potential need for thrombolytic therapy.
8. Gastrointestinal bleeding: with worsening gastrointestinal function and potential need for endoscopy and hemostasis.

I recommend close monitoring of the patient's vital signs, laboratory results, and clinical condition, with prompt intervention and management of any potential complications that arise."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP
   Low CVP
   Given multiple boluses
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP
   Low CVP
   Given multiple boluses
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the progress note, the patient is an 80-year-old male who was admitted with atypical chest pain, sepsis, and hypotension. He has a history of coronary artery disease, stroke, hypertension, chronic obstructive pulmonary disease (COPD), and is currently being treated for pneumonia (PNA) and a new diagnosis of liver metastases from colon cancer.

The patient's current condition is as follows:

* Vital signs: Temperature 36.6°C (97.8°F), heart rate 113 beats per minute, blood pressure 133/54 mmHg, respiratory rate 23 breaths per minute, and oxygen saturation 94%.
* Laboratory results: White blood cell count 23.8 K/uL, hemoglobin 9.9 g/dL, platelet count 150,000/uL, blood urea nitrogen 28.8 mg/dL, creatinine 2.5 mg/dL, and lactate dehydrogenase 495 IU/L.
* Fluid balance: The patient has received a total of 3,390 mL of fluids and has lost 1,040 mL of fluids, resulting in a positive fluid balance of 2,350 mL.
* Respiratory support: The patient is receiving oxygen therapy via a face tent and has an arterial blood gas (ABG) result of pH 7.34, partial pressure of carbon dioxide (pCO2) 26 mmHg, partial pressure of oxygen (pO2) 102 mmHg, and base excess (BE) -9 mmol/L.
* Physical examination: The patient's peripheral vascular, skin, and neurologic examinations are not assessable due to his condition.

The patient's medical complications include:

* Sepsis: The patient has a high risk of developing sepsis due to his pneumonia and liver metastases.
* Acute respiratory distress syndrome (ARDS): The patient's ABG results suggest that he may be at risk for developing ARDS.
* Acute kidney injury (AKI): The patient's creatinine level is elevated, and his urine output is low, suggesting that he may be at risk for developing AKI.
* Gastrointestinal (GI) bleeding: The patient's elevated lactate dehydrogenase (LDH) level and abdominal pain suggest that he may be at risk for developing GI bleeding.
* Hepatic failure: The patient's liver metastases and elevated LDH level suggest that he may be at risk for developing hepatic failure.

The patient's treatment plan includes:

* Antibiotics: The patient is receiving antibiotics for his pneumonia and liver metastases.
* Fluid management: The patient is receiving fluid boluses to maintain his blood pressure and urine output.
* Respiratory support: The patient is receiving oxygen therapy and may require mechanical ventilation if his condition worsens.
* Pain management: The patient is receiving pain medication for his chest pain and abdominal pain.
* Gastrointestinal (GI) support: The patient is receiving GI support medications to manage his nausea and vomiting.

In conclusion, the patient is a high-risk individual who requires close monitoring and management to prevent complications. His condition is complex, and he may require multiple interventions to manage his various medical issues."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP
   Low CVP; still responding to fluids
   Given multiple boluses
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP
   Low CVP; still responding to fluids
   Given multiple boluses
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   .
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's daily progress note, here is a summary of the information and potential medical complications that can arise:

**Patient Information:**

* Age: 80 years old
* Sex: Male
* Chief Complaint: Atypical chest pain
* Medical History: CAD, CVA, HTN, COPD, CABG, and CA metastatic to the liver

**Current Status:**

* Respiratory support: Face tent with O2 delivery
* Cardiovascular: Tachycardic with a heart rate of 113 bpm
* Hemodynamics: Low CVP, still responding to fluids
* Renal function: ARF with BUN/Cr ratio and low urine Na
* Liver function: Abnormal LFTs with elevated Alk phos and AST
* Metabolic: Gap metabolic acidosis with ABG showing met acidosis and resp alkalosis
* Infections: Sepsis suspected, with pending blood and urine cultures
* Gastrointestinal: Dysphagia, hiatal hernia, and aspiration precautions
* Other: Chronic back pain, hyperlipidemia, and chronic kidney disease

**Potential Medical Complications:**

1. **Cardiovascular:** Reversible lateral ST-depression, demand ischemia, and hypotension, which may lead to cardiac arrest.
2. **Respiratory:** Pneumonia, aspiration, and respiratory failure, which may require mechanical ventilation.
3. **Renal:** Acute kidney injury (AKI) with potential for dialysis, and chronic kidney disease progression.
4. **Liver:** Cholestatic pattern of liver dysfunction, which may lead to liver failure and require liver transplantation.
5. **Metabolic:** Metabolic acidosis, which may lead to further acid-base imbalances and organ dysfunction.
6. **Infections:** Sepsis, which may lead to multi-organ failure and death.
7. **Gastrointestinal:** Aspiration, which may lead to pneumonia and respiratory failure.
8. **Neurological:** Brain metastases, which may lead to neurological deficits and require neurosurgical intervention.

**Plan:**

* Continue to monitor the patient's vital signs, hemodynamics, and laboratory results.
* Titrate fluids to maintain CVP 8-12, MAP >65, and UOP >40.
* Continue antibiotic therapy for sepsis and respiratory/GI coverage.
* Consider diagnostic bronchoscopy and sputum cultures.
* Pursue contrast CT or MRCP for liver function evaluation.
* Consider head CT to evaluate for brain metastases.
* Continue aspiration precautions and consider speech/swallow therapy.
* Monitor for signs of cardiac, respiratory, and renal dysfunction.
* Adjust medication regimen as needed to manage hyperlipidemia, chronic kidney disease, and chronic back pain."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP; still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP; still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -d/c heparin gtt
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -start low-dose B-blocker if BP allows
   -telemetry
   .
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses, no pressor requirement
   - titrate fluids to CVP 8-12, MAP >65, UOP > 40
   -cont. vanco/zosyn for resp/GI cov
g (day [**6-26**]); cont. azithro (day
   [**5-18**]) for atypical cov
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -consider diagnostic bronch
   -aspiration precautions
   .
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   .
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   .
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no s/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   .
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   -TF
 no PO
s pending dysphagia w/u
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   .
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status:
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health status as follows:

The patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and colon cancer metastatic to the liver. He is currently in the intensive care unit (ICU) due to atypical chest pain, sepsis, and hypotension.

The patient's vital signs are:

* Temperature: 36.6°C (97.8°F)
* Heart rate: 113 beats per minute (bpm)
* Blood pressure: 133/54 mmHg
* Respiratory rate: 23 breaths per minute
* Oxygen saturation: 94%

The patient has a history of chest pain, which was initially treated with morphine and Maalox. His electrocardiogram (EKG) shows reversible lateral ST-depression, which is consistent with demand ischemia.

The patient is also experiencing sepsis, which is likely due to aspiration pneumonia (PNA), post-obstructive PNA from primary lung cancer, hepatobiliary source, or Clostridioides difficile (C. diff). His blood pressure has been responsive to intravenous fluid (IVF) boluses, and he has no pressor requirement.

The patient has a gap metabolic acidosis, which is contributing to his acid-base imbalance. His blood urea nitrogen (BUN) and creatinine (Cr) levels are elevated, indicating acute kidney injury (ARF). His urine output is low, and he has a Foley catheter in place.

The patient's liver function tests (LFTs) are abnormal, with elevated alkaline phosphatase (Alk phos), aspartate aminotransferase (AST), and bilirubin (T Bili) levels. His albumin level is low, and his international normalized ratio (INR) is elevated, suggesting diminished synthetic function.

The patient has dysphagia, which may be related to esophageal cancer or lung cancer with extrinsic compression. He is at high risk for aspiration and has a hiatal hernia on chest X-ray.

The patient has chronic obstructive pulmonary disease (COPD) and is being treated with prednisone taper and albuterol nebs as needed.

Potential medical complications that can arise include:

1. Sepsis: The patient is at risk for further complications due to sepsis, including organ failure, disseminated intravascular coagulation, and death.
2. ARF: The patient's acute kidney injury may worsen, leading to further electrolyte imbalances, fluid overload, and increased risk of infection.
3. Liver failure: The patient's abnormal LFTs may indicate liver failure, which can lead to coagulopathy, encephalopathy, and death.
4. Respiratory failure: The patient's COPD and sepsis may lead to respiratory failure, requiring mechanical ventilation.
5. Cardiac complications: The patient's history of coronary artery disease and demand ischemia may lead to cardiac complications, including arrhythmias, heart failure, and myocardial infarction.
6. Gastrointestinal complications: The patient's dysphagia and esophageal cancer may lead to gastrointestinal complications, including aspiration, obstruction, and perforation.
7. Infection: The patient is at risk for further infections, including ventilator-associated pneumonia (VAP) and catheter-associated urinary tract infections (CAUTIs).

Based on this information, I recommend the following:

1. Continue to monitor the patient's vital signs and laboratory results closely.
2. Optimize fluid management to maintain CVP, MAP, and UOP goals.
3. Consider repeat urine lytes, sediment, and renal ultrasound if no further improvement with hydration.
4. Dose medications accordingly for GFR < 20.
5. Pursue contrast CT or MRCP when clinically more stable to evaluate the patient's liver function.
6. Consider head CT to evaluate for brain metastases if the patient requires additional systemic anticoagulation.
7. Continue to manage the patient's pain and dysphagia with appropriate medications and interventions.
8. Consider speech and swallow evaluation when the patient is more stable.
9. Continue to monitor the patient's electrolyte levels and adjust medications as needed.
10. Consider discharge planning and rehabilitation services when the patient is clinically stable."
182947.0,210248,2182-08-26 06:34:00,Physician ,Physician Resident Progress Note,"Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing tachypneic on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:  pneumoboots, heparin drip
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: granddaughter [**Name (NI) 121**] (HCP)
   [**Name (NI) 156**] status: Full code
   Disposition: ICU
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Low UOP 15mL/hr
   Low CVP 2-4 this am; but still responding to fluids
   Given multiple boluses (1500mL IVF this am)
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-25**] 08:28 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-25**] 10:05 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-26**] 06:33 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 113 (90 - 124) bpm
   BP: 133/54(67) {0/0(0) - 0/0(0)} mmHg
   RR: 23 (16 - 32) insp/min
   SpO2: 94%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 7 (4 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                    565 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                    565 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    150 mL
   Urine:
                                                                  1,040 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                    415 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 94%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Gen: Labored breathing, states some pain remains, unable to localize
   his pain
   CV: Tachycardic, no M/R/G
   Lungs: decreased breath sounds, no wheezing/stridor anteriorly; labored
   breathing tachypneic on facemask, cough
   Abd: +bs, soft, ntnd
   Ext: 1+ edema of LLE,  mild edema of  BUE, 1+ distal pulses
   Labs / Radiology
   187 K/uL
   9.9 g/dL
   140 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.9 mEq/L
   80 mg/dL
   118 mEq/L
   145 mEq/L
   29.7 %
   23.8 K/uL
        [image002.jpg]
                             [**2182-8-23**]  02:55 AM
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   Plt
   [**Telephone/Fax (3) 150**]87
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   14
   15
   15
   Glucose
   155
   173
   137
   138
   140
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.1 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   20 Gauge - [**2182-8-23**] 12:58 AM
   18 Gauge - [**2182-8-23**] 12:58 AM
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:  pneumoboots, heparin drip
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments: granddaughter [**Name (NI) 121**] (HCP)
   [**Name (NI) 156**] status: Full code
   Disposition: ICU<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the physician's daily progress note, I summarize the patient's health progress in the ICU as follows:

The patient is an 80-year-old male with a history of coronary artery disease (CAD) post-coronary artery bypass grafting (CABG), cerebrovascular accident (CVA), hypertension (HTN), chronic obstructive pulmonary disease (COPD), and metastatic cancer to the liver. He was admitted with atypical chest pain, sepsis, and hypotension.

The patient's vital signs are as follows:

* Temperature: 36.6°C (97.8°F)
* Heart rate: 113 beats per minute (bpm)
* Blood pressure: 133/54 mmHg
* Respiratory rate: 23 breaths per minute
* Oxygen saturation: 94%

The patient's laboratory results show:

* White blood cell count: 23.8 K/uL
* Hemoglobin: 9.9 g/dL
* Platelet count: 87 K/uL
* Blood urea nitrogen (BUN): 140 mg/dL
* Creatinine (Cr): 2.6 mg/dL
* Glucose: 155 mg/dL
* Lactic acid: 1.9 mmol/L
* Albumin: 2.1 g/dL
* LDH: 495 IU/L
* Calcium: 8.1 mg/dL
* Magnesium: 2.5 mg/dL
* Phosphorus: 4.4 mg/dL

The patient's medical conditions include:

* Sepsis: likely due to aspiration pneumonia (PNA) or post-obstructive PNA from a primary lung cancer, hepatobiliary source, or Clostridium difficile (C. diff)
* Hypotension: responsive to intravenous fluid (IVF) boluses
* Chest pain syndrome: reversible lateral ST-depression associated with atypical chest pain, demand ischemia, and sepsis
* Acute kidney injury (ARF): pre-renal azotemia, low urine sodium, and cellular casts in sediment
* Abnormal liver function tests (LFTs): diffuse metastatic disease, low albumin, and elevated INR
* Dysphagia: c/o esophageal cancer or lung cancer with extrinsic esophageal compression
* COPD: no acute exacerbation
* HTN: holding antihypertensives while BP is low
* Hyperlipidemia: holding crestor due to elevated LFTs
* Chronic back pain: lidocaine patch, avoiding NSAIDs and tylenol

The patient's treatment plan includes:

* Repeat echocardiogram to evaluate acute change in cardiac function
* Titrate fluids to CVP 8-12, MAP >65, and UOP > 30
* Blood, urine, and sputum cultures pending
* Continue vancomycin and zosyn for respiratory and gastrointestinal coverage
* Aspiration precautions
* Consider pulmonary embolism (PE) as an obstructive cause for tachycardia
* Restart heparin drip
* Attempt NG tube placement today
* Continue outpatient INH meds
* Albuterol nebs PRN
* Chest PT
* INH moisturized air for dry mouth
* Incentive spirometry

Potential medical complications that can arise include:

* Sepsis-related organ dysfunction
* ARF progression
* Cholestatic liver disease
* Aspiration pneumonia
* Pulmonary embolism
* Gastrointestinal bleeding
* Respiratory failure
* Cardiac arrhythmias
* Metabolic acidosis
* Electrolyte imbalances
* Hypoglycemia

Based on the patient's condition, it is crucial to closely monitor his vital signs, laboratory results, and clinical status to prevent potential complications and ensure optimal care."
182947.0,210248,2182-08-26 10:51:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Sepsis-Secondary to PNA
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Patient with some tachycardia persisting during event
   -Tachycardia-
   -CVP was decreased
   -Patient with continued increased thirst
   -3 liters given over past 24 hours
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 08:48 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-26**] 09:16 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue
   Cardiovascular: Tachycardia
   Flowsheet Data as of  [**2182-8-26**] 10:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 122 (90 - 126) bpm
   BP: 105/42(58) {104/42(58) - 105/48(63)} mmHg
   RR: 24 (16 - 26) insp/min
   SpO2: 97%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
   CVP: 7 (3 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                  2,226 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                  2,226 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    330 mL
   Urine:
                                                                  1,040 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                  1,896 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 97%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic: CVP shows significant
   inspiratory fall
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Distant), Tachcardia.
   distant
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Diminished: ), Increased tachypnea
   Abdominal: Soft
   Extremities: Right: Trace, Left: 2+
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   10.0 g/dL
   194 K/uL
   136 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.8 mEq/L
   84 mg/dL
   116 mEq/L
   143 mEq/L
   29.8 %
   23.6 K/uL
        [image002.jpg]
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   23.6
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   29.8
   Plt
   [**Telephone/Fax (3) 150**]87
   194
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   15
   15
   Glucose
   155
   173
   137
   138
   140
   136
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.4 mg/dL, PO4:4.5 mg/dL
   Imaging: CXR [**2182-8-26**]-
   CVL into R atrium
   Bilateral pleural effusions suggested
   Some evidence of increased interstitial markings
   Has some suggestion of left upper lobe intfiltrate
   Assessment and Plan
   80 yo male with admission with concering symptoms of chest pain in the
   setting of pneumonia and now has evidence of metastatic disease in the
   liver but with primary tumor not well defined.  He now has hospital
   course significant for persistent intermittent episodes of chest
   discomfort and now maintains a resting tachycardia.  This raises
   significant concern in the setting of rising WBC count and suggestion
   of lower extermity edema.
   1)Tachycardia-The differential for this is broad.  He clearly has it
   persistent with wake or sleep state to make anxiety/pain as source of
   tachycardia much less likely.  He has significant inspiratory fall in
   CVP trace with respiration and admits to thirst which is suggestive of
   some volume depletion.  This is argued against by the bilateral pleural
   effusions and increased intersitial markings.  He has had transient
   response to fluids only.   Will need to determine source
   -Check CvO2
   -F/U with fluid bolus changes to look for response
   -Check albumin for oncotic pressure at this time
   -Echo is reasonable for conern of evolution in pericardial effusion in
   setting of pleural effusions if not stabilized.
   -PE raised as a possibility and in absence of capacity to use
   alternative explanations may need to continue Rx with empiric heparin
   if altenative sources not seen and improvement not achieved.
   -Further evaluation and treatment will have to be driven by source of
   circulatory compromise.
   2)Coronary Artery Disease-Patient with intermittent chest discomfort
   which is reversed with supportive Rx.  He has had no signs of new
   myocardial infarction but has concerning intermittent symptoms to
   suggest demand ischemia.
   -Will continue to monitor symptoms and treat as needed with TNG and f/u
   enzymes
   -Heparin D/C
d at this time
   3)Pneumonia
no new culture results, continue with Abx at this time.  He
   has bilateral pleural effisions with little evidence of unilateral
   predominance.   He has had an increase in WBC  count at this time which
   is of concern.
   -Continue with antibiotics
   -Will need to evaluate pleural effusions with thoracentesis for
   recurrent fever although it is suggestive of hydrostatic source.
   -Will increase steroid dosing as expected benefit for airways
   obstruction and possible source of vasodilatory state would be expected
   to benefit.
   4)Hepatic Metastatic Disease
Source is unclear, will need continued
   evaluation based on clinical stability.
   ICU Care
   Nutrition: NPO
NGT to be placed.
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis-Secondary to PNA
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 CHEST PAIN - At [**2182-8-26**] 02:37 AM
   given 1 tab sl, 2mg IVP morphine, and 30cc maalox
   Patient with some tachycardia persisting during event
   -Tachycardia-
   -CVP was decreased
   -Patient with continued increased thirst
   -3 liters given over past 24 hours
   History obtained from [**Hospital 19**] Medical records
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 08:48 AM
   Infusions:
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-26**] 09:16 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue
   Cardiovascular: Tachycardia
   Flowsheet Data as of  [**2182-8-26**] 10:26 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.6
C (97.8
   Tcurrent: 36.6
C (97.8
   HR: 122 (90 - 126) bpm
   BP: 105/42(58) {104/42(58) - 105/48(63)} mmHg
   RR: 24 (16 - 26) insp/min
   SpO2: 97%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
   CVP: 7 (3 - 12)mmHg
   Total In:
                                                                  3,390 mL
                                                                  2,226 mL
   PO:
   TF:
   IVF:
                                                                  3,390 mL
                                                                  2,226 mL
   Blood products:
   Total out:
                                                                  1,040 mL
                                                                    330 mL
   Urine:
                                                                  1,040 mL
                                                                    330 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  2,350 mL
                                                                  1,896 mL
   Respiratory support
   O2 Delivery Device: Face tent
   SpO2: 97%
   ABG: 7.34/26/102/14/-9
   PaO2 / FiO2: 291
   Physical Examination
   Eyes / Conjunctiva: PERRL
   Head, Ears, Nose, Throat: Normocephalic: CVP shows significant
   inspiratory fall
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Distant), Tachcardia.
   distant
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds:
   Diminished: ), Increased tachypnea
   Abdominal: Soft
   Extremities: Right: Trace, Left: 2+
   Skin:  Not assessed
   Neurologic: Attentive, Follows simple commands, Responds to: Not
   assessed, Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   10.0 g/dL
   194 K/uL
   136 mg/dL
   2.5 mg/dL
   14 mEq/L
   3.8 mEq/L
   84 mg/dL
   116 mEq/L
   143 mEq/L
   29.8 %
   23.6 K/uL
        [image002.jpg]
                             [**2182-8-23**]  04:44 AM
                             [**2182-8-23**]  12:27 PM
                             [**2182-8-23**]  12:48 PM
                             [**2182-8-23**]  09:42 PM
                             [**2182-8-24**]  05:03 AM
                             [**2182-8-24**]  07:28 AM
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
   WBC
   15.8
   19.5
   21.8
   23.8
   23.6
   Hct
   28.8
   29.1
   30.4
   30.2
   31.6
   29.7
   29.8
   Plt
   [**Telephone/Fax (3) 150**]87
   194
   Cr
   2.8
   2.5
   2.5
   2.6
   2.5
   2.5
   TropT
   <0.01
   <0.01
   0.01
   0.02
   0.03
   TCO2
   15
   15
   Glucose
   155
   173
   137
   138
   140
   136
   Other labs: PT / PTT / INR:16.9/29.5/1.5, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:106/219, Alk Phos / T Bili:750/2.9,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:1.9 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.4 mg/dL, PO4:4.5 mg/dL
   Imaging: CXR [**2182-8-26**]-
   CVL into R atrium
   Bilateral pleural effusions suggested
   Some evidence of increased interstitial markings
   Has some suggestion of left upper lobe intfiltrate
   Assessment and Plan
   80 yo male with admission with concering symptoms of chest pain in the
   setting of pneumonia and now has evidence of metastatic disease in the
   liver but with primary tumor not well defined.  He now has hospital
   course significant for persistent intermittent episodes of chest
   discomfort and now maintains a resting tachycardia.  This raises
   significant concern in the setting of rising WBC count and suggestion
   of lower extermity edema.
   1)Tachycardia-The differential for this is broad.  He clearly has it
   persistent with wake or sleep state to make anxiety/pain as source of
   tachycardia much less likely.  He has significant inspiratory fall in
   CVP trace with respiration and admits to thirst which is suggestive of
   some volume depletion.  This is argued against by the bilateral pleural
   effusions and increased intersitial markings.  He has had transient
   response to fluids only.   Will need to determine source
   -Check CvO2
   -F/U with fluid bolus changes to look for response
   -Check albumin for oncotic pressure at this time
   -Echo is reasonable for conern of evolution in pericardial effusion in
   setting of pleural effusions if not stabilized.
   -PE raised as a possibility and in absence of capacity to use
   alternative explanations may need to continue Rx with empiric heparin
   if altenative sources not seen and improvement not achieved.
   -Further evaluation and treatment will have to be driven by source of
   circulatory compromise.
   2)Coronary Artery Disease-Patient with intermittent chest discomfort
   which is reversed with supportive Rx.  He has had no signs of new
   myocardial infarction but has concerning intermittent symptoms to
   suggest demand ischemia.
   -Will continue to monitor symptoms and treat as needed with TNG and f/u
   enzymes
   -Heparin D/C
d at this time
   3)Pneumonia
no new culture results, continue with Abx at this time.  He
   has bilateral pleural effisions with little evidence of unilateral
   predominance.   He has had an increase in WBC  count at this time which
   is of concern.
   -Continue with antibiotics
   -Will need to evaluate pleural effusions with thoracentesis for
   recurrent fever although it is suggestive of hydrostatic source.
   -Will increase steroid dosing as expected benefit for airways
   obstruction and possible source of vasodilatory state would be expected
   to benefit.
   4)Hepatic Metastatic Disease
Source is unclear, will need continued
   evaluation based on clinical stability.
   ICU Care
   Nutrition: NPO
NGT to be placed.
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: Boots, SQ UF Heparin(Systemic anticoagulation: None)
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male admitted to the ICU with sepsis secondary to pneumonia. He has a history of metastatic disease in the liver, but the primary tumor is not well-defined. The patient has been experiencing persistent intermittent episodes of chest discomfort and now has a resting tachycardia. He has a rising white blood cell count and bilateral pleural effusions.

The patient's vital signs are:

* Temperature: 36.6°C (97.8°F)
* Heart rate: 122 bpm (90-126 bpm)
* Blood pressure: 105/42 mmHg (58-63 mmHg)
* Respiratory rate: 24 inspirations per minute
* Oxygen saturation: 97%

The patient's physical examination reveals:

* Tachycardia
* Decreased CVP with inspiratory fall
* Increased thirst
* Bilateral pleural effusions
* Soft abdomen
* Right leg edema (2+), left leg edema (trace)

The patient's laboratory results show:

* White blood cell count: 23.6 K/uL
* Hemoglobin: 10.0 g/dL
* Platelet count: 87 K/uL
* Creatinine: 2.5 mg/dL
* Troponin-T: 0.03 ng/mL
* Lactic acid: 1.9 mmol/L
* Albumin: 2.1 g/dL
* LDH: 495 IU/L
* Calcium: 8.2 mg/dL
* Magnesium: 2.4 mg/dL
* Phosphate: 4.5 mg/dL

The patient's imaging studies show:

* CXR: bilateral pleural effusions, increased interstitial markings, and possible left upper lobe infiltrate

Potential Medical Complications:

1. Tachycardia: The patient's tachycardia is persistent and not responsive to fluids, suggesting a possible cardiac origin. The patient's history of coronary artery disease and the presence of bilateral pleural effusions raise concerns for cardiac compromise.
2. Coronary Artery Disease: The patient's intermittent chest discomfort, which is reversed with supportive therapy, suggests demand ischemia. The patient's tachycardia and rising white blood cell count may indicate cardiac instability.
3. Pneumonia: The patient's bilateral pleural effusions and rising white blood cell count suggest ongoing infection. The patient's history of pneumonia and the presence of bilateral pleural effusions raise concerns for recurrent or chronic infection.
4. Hepatic Metastatic Disease: The patient's metastatic disease in the liver is not well-defined, and the patient's clinical stability is uncertain. The patient's rising white blood cell count and bilateral pleural effusions may indicate ongoing disease progression.

The patient requires continued evaluation and treatment for these potential complications, including further imaging studies, laboratory tests, and pharmacological therapy."
182947.0,210248,2182-08-27 06:22:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Respiratory distress
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   1. Large mass centered within the mediastinum in the chest, with
   extension
   into the left hilum, likely reflecting the site of patient's primary
   malignancy.
   2. Numerous bulky mediastinal lymph nodes.
   3. Bilateral pleural effusions, with patchy airspace opacities, likely
   areas
   of aspiration.
   4. Known numerous hepatic lesions are not appreciated without IV
   contrast.
   5. Cholelithiasis.
   6. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   1. Large mass centered within the mediastinum in the chest, with
   extension
   into the left hilum, likely reflecting the site of patient's primary
   malignancy.
   2. Numerous bulky mediastinal lymph nodes.
   3. Bilateral pleural effusions, with patchy airspace opacities, likely
   areas
   of aspiration.
   4. Known numerous hepatic lesions are not appreciated without IV
   contrast.
   5. Cholelithiasis.
   6. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided daily progress note, the patient is a 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and cholelithiasis. He is currently admitted to the intensive care unit (ICU) with respiratory distress, sepsis, and hypotension.

The patient's vital signs are:

* Temperature: 37.6°C (99.6°F)
* Heart rate: 117 beats per minute (bpm)
* Blood pressure: 93/53 mmHg
* Respiratory rate: 20 breaths per minute
* Oxygen saturation: 100%
* Central venous pressure (CVP): 9 mmHg
* Mixed venous oxygen saturation: 62-69%

The patient's laboratory results show:

* White blood cell count (WBC): 21.8-24.7 x 10^9/L
* Hemoglobin (Hb): 9.8-10.3 g/dL
* Platelet count (PLT): 93-140 x 10^9/L
* Creatinine (Cr): 2.5-2.6 mg/dL
* Blood urea nitrogen (BUN): 15-16 mmol/L
* Electrolytes: sodium (Na): 138-140 mmol/L, potassium (K): 4.4-4.7 mmol/L, chloride (Cl): 88-119 mmol/L, calcium (Ca): 8.2-8.5 mg/dL, magnesium (Mg): 2.5-2.8 mg/dL, phosphorus (P): 4.4-4.8 mg/dL
* Liver function tests (LFTs): alanine aminotransferase (ALT): 116-201 IU/L, aspartate aminotransferase (AST): 116-201 IU/L, alkaline phosphatase (ALK): 600-650 IU/L, total bilirubin (T Bili): 2.8-3.2 mg/dL
* Cardiac enzymes: troponin-T: 0.02-0.03 ng/mL, creatine kinase (CK): 118-154 IU/L, creatine kinase MB (CKMB): 6-7 IU/L

The patient's imaging studies show:

* Echocardiogram: small left ventricular cavity with hyperdynamic left ventricular systolic function, dilated and hypokinetic right ventricle, mild mitral regurgitation, and a mediastinal mass compressing the heart.
* Non-contrast computed tomography (CT) abdomen and pelvis: large mass centered in the mediastinum, extension into the left hilum, likely reflecting the site of the patient's primary malignancy, numerous bulky mediastinal lymph nodes, bilateral pleural effusions, patchy airspace opacities, and cholelithiasis.

The patient's diagnosis is:

* Sepsis
* Respiratory failure
* Hypotension
* Cardiac failure
* Metastatic cancer to the liver
* Chronic obstructive pulmonary disease (COPD)
* Cholelithiasis
* Hyperlipidemia
* Chronic back pain
* Dysphagia
* Abnormal liver function tests (LFTs)

The patient's plan of care includes:

* Repeat echocardiogram to evaluate acute changes in cardiac function
* Titrate fluids to maintain CVP 8-12 mmHg and MAP >65 mmHg
* Continue vancomycin and piperacillin/tazobactam for respiratory and gastrointestinal coverage
* Aspiration precautions
* Consider pulmonary embolism as an obstructive cause for tachycardia
* Restart heparin infusion
* Follow ABGs to monitor for metabolic acidosis
* Consider head CT to evaluate for brain metastases if the patient requires additional systemic anticoagulation
* Attempt nasogastric tube placement
* Continue outpatient medications, including inhaled corticosteroids and bronchodilators
* Hold antihypertensives while blood pressure is low
* Hold crestor due to elevated LFTs
* Avoid nonsteroidal anti-inflammatory drugs (NSAIDs) and ibuprofen due to risk of gastrointestinal bleeding and acute kidney injury
* Avoid acetaminophen due to elevated LFTs
* Consider speech and swallow evaluation when clinically more stable."
182947.0,210248,2182-08-27 06:22:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Respiratory distress, sepsis,
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Echo: revealed mediastinal mass
   Chest CT: mediastinal mass likely primary cancer, bilateral pleural
   effusions
   Difficulty maintaining MAP > 60; and CVP > 8
   Decline in mental status/ increased confusion overnight
   Meeting with granddaughter yesterday to discuss imaging results and
   goals of treatment.
   Pt started on levophed drip
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Gen: moderate distress, increased respiratory effort, responds to name;
   answers yes/no questions
   CV: tachycardic, loud S1 S2, no M/R/G
   Lungs:  coarse bs bilaterally, moderate- severe respiratory effort on
   60% facemask
   Abd: soft, ntnd, decreased bs
   Ext: warm, dry, diffuse edema, 2+ radial pulses
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   1. Large mass centered within the mediastinum in the chest, with
   extension
   into the left hilum, likely reflecting the site of patient's primary
   malignancy.
   2. Numerous bulky mediastinal lymph nodes.
   3. Bilateral pleural effusions, with patchy airspace opacities, likely
   areas
   of aspiration.
   4. Known numerous hepatic lesions are not appreciated without IV
   contrast.
   5. Cholelithiasis.
   6. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress, sepsis,
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Echo: revealed mediastinal mass
   Chest CT: mediastinal mass likely primary cancer, bilateral pleural
   effusions
   Difficulty maintaining MAP > 60; and CVP > 8
   Decline in mental status/ increased confusion overnight
   Meeting with granddaughter yesterday to discuss imaging results and
   goals of treatment.
   Pt started on levophed drip
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Gen: moderate distress, increased respiratory effort, responds to name;
   answers yes/no questions
   CV: tachycardic, loud S1 S2, no M/R/G
   Lungs:  coarse bs bilaterally, moderate- severe respiratory effort on
   60% facemask
   Abd: soft, ntnd, decreased bs
   Ext: warm, dry, diffuse edema, 2+ radial pulses
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   1. Large mass centered within the mediastinum in the chest, with
   extension
   into the left hilum, likely reflecting the site of patient's primary
   malignancy.
   2. Numerous bulky mediastinal lymph nodes.
   3. Bilateral pleural effusions, with patchy airspace opacities, likely
   areas
   of aspiration.
   4. Known numerous hepatic lesions are not appreciated without IV
   contrast.
   5. Cholelithiasis.
   6. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male who was admitted to the ICU with respiratory distress, sepsis, and hypotension. The patient has a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease, and colon cancer metastatic to the liver.

The patient's current condition is as follows:

* Respiratory: The patient has a severe respiratory distress with a need for high-flow nasal oxygen and mechanical ventilation. The patient's arterial blood gas (ABG) shows a pH of 7.35, PCO2 of 28, and PO2 of 74, indicating a respiratory alkalosis.
* Cardiovascular: The patient has a tachycardia with a heart rate of 117 beats per minute, and a blood pressure of 93/53 mmHg, indicating a hypotension. The patient's electrocardiogram (EKG) shows a sinus tachycardia with lateral ST depression.
* Renal: The patient has acute kidney injury (AKI) with a blood urea nitrogen (BUN) of 193 mg/dL and a creatinine (Cr) of 2.6 mg/dL. The patient's urine output is 679 mL, and the patient has a Foley catheter in place.
* Hepatic: The patient has elevated liver enzymes, including alkaline phosphatase (Alk Phos) of 600 IU/L, aspartate aminotransferase (AST) of 201 IU/L, and alanine aminotransferase (ALT) of 116 IU/L.
* Metabolic: The patient has a metabolic acidosis with a pH of 7.35, bicarbonate of 12 mmol/L, and a base excess of -8 mmol/L.
* Infectious: The patient has a sepsis with a suspected source of aspiration pneumonia, and the patient is receiving antibiotics.

The patient's potential medical complications include:

* Respiratory failure: The patient's severe respiratory distress may lead to respiratory failure, which could be life-threatening.
* Cardiac arrest: The patient's tachycardia and hypotension may increase the risk of cardiac arrest.
* Renal failure: The patient's AKI may worsen and lead to renal failure, which could require dialysis.
* Hepatic failure: The patient's elevated liver enzymes may indicate liver failure, which could lead to coagulopathy and bleeding.
* Metabolic acidosis: The patient's metabolic acidosis may worsen and lead to cardiac arrest, respiratory failure, or other complications.
* Sepsis: The patient's sepsis may worsen and lead to multi-organ failure, including respiratory, cardiovascular, and renal failure.

The patient's plan of care includes:

* Repeat echocardiogram to evaluate acute change in cardiac function
* Titrate fluids to CVP 8-12, MAP >65, and UOP > 30
* Blood, urine, and sputum cultures pending
* Continue antibiotics for respiratory and gastrointestinal coverage
* Consider pulmonary embolism as an obstructive cause for tachycardia
* Restart heparin drip
* Attempt NG tube placement today
* Consider head CT to evaluate for brain metastases if the patient requires additional systemic anticoagulation.

In conclusion, the patient is a high-risk individual with multiple comorbidities and a severe respiratory distress, sepsis, and hypotension. The patient's potential medical complications are significant, and the patient requires close monitoring and aggressive management to prevent and treat these complications."
182947.0,210248,2182-08-27 06:22:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Respiratory distress, sepsis, pneumonia
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   [**8-26**] Echo: revealed mediastinal mass
   [**8-26**] Chest CT: mediastinal mass likely primary cancer, bilateral
   pleural effusions
   NG tube placement unsuccessful.
   Difficulty maintaining MAP > 60; and CVP > 8
   CVP responsive to fluid boluses (received total of 2.5 L overnight) but
   MAP remained low.  Pt then started on levophed drip.  Currently on 0.09
   Decline in mental status/ increased confusion overnight
   Meeting with granddaughter yesterday to discuss imaging results and
   goals of treatment.  Granddaughter and wife to return today to finalize
   goals of treatment.
   Heme/Onc consulted about medialstinal/lung mass and liver mets.  Due to
   dependence on pressors, chemotherapy would not be an option at this
   time.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Gen: moderate distress, increased respiratory effort, responds to name;
   answers yes/no questions
   CV: tachycardic, loud S1 S2, no M/R/G
   Lungs:  coarse bs bilaterally, moderate- severe respiratory effort on
   60% facemask
   Abd: soft, ntnd, decreased bs
   Ext: warm, dry, diffuse edema, 2+ radial pulses
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   Large mass centered within the mediastinum in the chest w/ extension
   into L hilum.  Numerous bulky mediastinal LNs.  Bilateral pleural
   effusions with patchy airspace opacities, likely areas of aspiration.
   Cholelithiasis. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
    #Respiratory distress: etiology likely multifactorial, aspiration PNA
   vs obstructive PNA vs bilateral effusions vs lung mass.
   - continue antibiotic treatment
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   - titrate O2 to SpO2 >90%
   - serial ABG to evaluate need for intubation
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.  Medialstinal mass
   may contribute to hemodynamic instability.
   -          titrate fluids to CVP 8-12 and UOP > 20 mL/hr
   -          Continue Levophed drip to maintain MAP >60
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; give final dose of azithro
   today IV due to patient
s difficulty with po intake
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia in the face of RV
   dilitation; restart heparin gtt; cannot obtain contrast CT due to ARF
   at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]  (per rectal due to pts difficulty with po intake)
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
    -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
    -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
    -may pursue contrast CT vs. MRCP if pt becomes more clinically stable,
   renal fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
    -GI C/S re: utility of EGD if becomes clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S if becomes more stable
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   #Hyperlipidemia
    -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
    -lidocaine patch
    -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
    -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
    -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
    - NG tube placement will likely require endoscopy.  Pt currently too
   unstable to undergo endoscopy at this time.  If pt
s family express
   wishes for aggressive care will discuss the option of TPN.
   .
   #PPx - PPI, Heparin gtt
    #Access - R IJ, PIV; art-line
    #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
    patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP).  Meeting
   scheduled for today with HCP to discuss goals of treatment.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress, sepsis, pneumonia
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   [**8-26**] Echo: revealed mediastinal mass
   [**8-26**] Chest CT: mediastinal mass likely primary cancer, bilateral
   pleural effusions
   NG tube placement unsuccessful.
   Difficulty maintaining MAP > 60; and CVP > 8
   CVP responsive to fluid boluses (received total of 2.5 L overnight) but
   MAP remained low.  Pt then started on levophed drip.  Currently on 0.09
   Decline in mental status/ increased confusion overnight
   Meeting with granddaughter yesterday to discuss imaging results and
   goals of treatment.  Granddaughter and wife to return today to finalize
   goals of treatment.
   Heme/Onc consulted about medialstinal/lung mass and liver mets.  Due to
   dependence on pressors, chemotherapy would not be an option at this
   time.
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Gen: moderate distress, increased respiratory effort, responds to name;
   answers yes/no questions
   CV: tachycardic, loud S1 S2, no M/R/G
   Lungs:  coarse bs bilaterally, moderate- severe respiratory effort on
   60% facemask
   Abd: soft, ntnd, decreased bs
   Ext: warm, dry, diffuse edema, 2+ radial pulses
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   [**2182-8-26**] Echo: Somewhat small LV cavity with hyperdynamic LV systolic
   function. Dilated and hypokinetic RV. Mild mitral regurgitation.
   There is a mediastinal mass compressing the heart. This mass appears to
   be in the left pleural space. It measures 6 x 4.5 cm approximately and
   has similar echo density to lung tissue. There may be focal areas of
   calcification within the mass. It is impinging on the posterior wall of
   the left atrium but does not seem to be impairing cardiac filling. Mild
   mitral regurgitation.
   Compared with the prior study (images reviewed) of [**2182-8-23**], the right
   ventricle appears mildly dilated and hypokinetic. There is now a large
   left pleural effusion. There is a mass seen within the effusion which
   was probably there on prior echo but not seen as it was iso-dense with
   the surrounding lung tissue. It can now be delineated because it is now
   surrounded by fluid.
   [**2182-8-26**] Noncontrast CT abd/pelvis:
   Large mass centered within the mediastinum in the chest w/ extension
   into L hilum.  Numerous bulky mediastinal LNs.  Bilateral pleural
   effusions with patchy airspace opacities, likely areas of aspiration.
   Cholelithiasis. Ascites.
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
    #Respiratory distress: etiology likely multifactorial, aspiration PNA
   vs obstructive PNA vs bilateral effusions vs lung mass.
   - continue antibiotic treatment
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   - titrate O2 to SpO2 >90%
   - serial ABG to evaluate need for intubation
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.  Medialstinal mass
   may contribute to hemodynamic instability.
   -          titrate fluids to CVP 8-12 and UOP > 20 mL/hr
   -          Continue Levophed drip to maintain MAP >60
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; give final dose of azithro
   today IV due to patient
s difficulty with po intake
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia in the face of RV
   dilitation; restart heparin gtt; cannot obtain contrast CT due to ARF
   at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]  (per rectal due to pts difficulty with po intake)
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
    -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
    -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
    -may pursue contrast CT vs. MRCP if pt becomes more clinically stable,
   renal fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
    -GI C/S re: utility of EGD if becomes clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S if becomes more stable
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   #Hyperlipidemia
    -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
    -lidocaine patch
    -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
    -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   #F/E/N
    -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
    - NG tube placement will likely require endoscopy.  Pt currently too
   unstable to undergo endoscopy at this time.  If pt
s family express
   wishes for aggressive care will discuss the option of TPN.
   .
   #PPx - PPI, Heparin gtt
    #Access - R IJ, PIV; art-line
    #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
    patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP).  Meeting
   scheduled for today with HCP to discuss goals of treatment.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is an 80-year-old male who was admitted to the ICU with respiratory distress, sepsis, and pneumonia. He has a history of CAD, CVA, HTN, COPD, and is currently undergoing treatment for a newly diagnosed primary lung cancer with metastases to the liver. The patient's condition is complex and multifactorial, with several potential causes for his respiratory distress, including aspiration pneumonia, obstructive pneumonia, bilateral pleural effusions, and lung mass.

Potential Medical Complications:

1. Respiratory failure: The patient's respiratory distress is likely to worsen if not properly managed, leading to respiratory failure and potentially requiring intubation.
2. Sepsis: The patient's sepsis is likely to progress if not treated promptly and effectively, leading to organ failure and potentially fatal outcomes.
3. Cardiac instability: The patient's mediastinal mass may be compressing his heart, leading to cardiac instability and potentially life-threatening arrhythmias.
4. Renal failure: The patient's acute kidney injury (AKI) is likely to worsen if not properly managed, leading to chronic kidney disease and potentially fatal outcomes.
5. Metabolic acidosis: The patient's metabolic acidosis is likely to worsen if not properly managed, leading to further organ dysfunction and potentially fatal outcomes.
6. Aspiration pneumonia: The patient's aspiration pneumonia is likely to worsen if not properly managed, leading to respiratory failure and potentially fatal outcomes.
7. Cholestatic liver disease: The patient's cholestatic liver disease is likely to worsen if not properly managed, leading to liver failure and potentially fatal outcomes.
8. Hyperlipidemia: The patient's hyperlipidemia is likely to worsen if not properly managed, leading to further cardiovascular complications and potentially fatal outcomes.

Recommendations:

1. Continue antibiotic treatment for pneumonia and sepsis.
2. Monitor the patient's respiratory status closely and consider intubation if necessary.
3. Monitor the patient's cardiac status closely and consider cardiology consultation if necessary.
4. Monitor the patient's renal function closely and consider nephrology consultation if necessary.
5. Monitor the patient's metabolic status closely and consider endocrinology consultation if necessary.
6. Consider imaging studies (e.g., CT scan, MRI) to further evaluate the patient's mediastinal mass and potential cardiac compression.
7. Consider gastroenterology consultation to further evaluate the patient's cholestatic liver disease and potential biliary obstruction.
8. Consider lipid-lowering therapy to manage the patient's hyperlipidemia.

Overall, the patient's condition is complex and requires close monitoring and management by a multidisciplinary team of healthcare providers."
182947.0,210248,2182-08-27 06:22:00,Physician ,Physician Resident Progress Note,"Chief Complaint: Respiratory distress
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-26**] 11:57 PM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.03 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-26**] 08:48 AM
   Heparin Sodium (Prophylaxis) - [**2182-8-26**] 08:48 AM
   Morphine Sulfate - [**2182-8-27**] 04:30 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 06:22 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 117 (116 - 125) bpm
   BP: 93/53(69) {84/44(61) - 93/53(69)} mmHg
   RR: 20 (20 - 26) insp/min
   SpO2: 100%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
    CVP: 9 (3 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
   Total In:
                                                                  4,377 mL
                                                                  1,153 mL
   PO:
   TF:
   IVF:
                                                                  4,377 mL
                                                                  1,153 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    140 mL
   Urine:
                                                                    679 mL
                                                                    140 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,013 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 100%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Skin:  Not assessed
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   193 K/uL
   9.8 g/dL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 y/o M h/o CAD s/p CABG, CVA, HTN, COPD p/w atypical chest pain,
   sepsis, and hypotension in the setting of PNA and a new diagnosis of CA
   metastatic to the liver.
   #Sepsis - Most likely from aspiration PNA, also consider
   post-obstructive PNA from ? primary lung CA, hepatobiliary source, C.
   diff; BP has been responsive to IVF boluses but remains low.    Pt is
   currently tachycardic in the face of hypotension.
   - Repeat echo today: to evaluate acute change in cardiac function
   - titrate fluids to CVP 8-12, MAP >65, UOP > 30
   -blood, urine Cx pending; will send C. diff toxin (but refrain from
   treating unless pos) and sputum Cx if possible
   -PNA: cont. vanco/zosyn for resp/GI cov
g; cont. azithro for atypical
   cov
   -aspiration precautions
   -consider PE as obstructive cause for tachycardia; look at echo;
   restart heparin gtt; cannot obtain contrast CT due to ARF at this time.
   #gap metabolic acidosis -  ABG c/w met acidosis + resp alkalosis;
   contributing etiologies incl. ARF, NS expansion acidosis, resolving
   lactic acidosis
   -LR for volume repletion in light of hyperchloremia
   -follow ABGs
   #Chest pain syndrome
 reversible lateral ST-depr. assoc. with atypical
   chest pain c/w demand ischemia in the setting of low diastolic BP
   sepsis - neg CE
s, absence of WMA on echo; tx with heparin gtt x 48 h;
   most recent episode of pain not assoc. with EKG changes and resolved
   with maalox
   -morphine, nitro SL PRN
   -cont. [**Last Name (LF) 120**], [**First Name3 (LF) 119**]
   -telemetry
   #ARF - BUN/Cr ratio, low urine NA c/w pre-renal azotemia, however Cr
   has leveled off above b/l after aggressive volume repletion; cellular
   casts in sediment invokes AIN vs. ATN vs. GN; foley in place, draining
   so low c/f obstruction
   -goal UOP > 40 cc/hr
   -cont. volume repletion as above, consider repeat urine lytes,
   sediment, renal U/S if no further improvement with hydration
   -dose meds for GFR<20
   #Abnormal LFT's
 stable; diffuse metastatic disease (? esophageal vs.
   lung vs. colon primary) by RUQ U/S, but could not adequately visualize
   biliary tree. Low albumin/elevated INR suggest diminished synthetic
   function. Markedly elevated Alk phos/AST with T Bili 2X ULN suggests a
   cholestatic pattern of such as intrahepatic cholestasis (i.e. in the
   setting of sepsis) or biliary obstruction (given high amylase/lipase)
   -will pursue contrast CT vs. MRCP when clinically more stable, renal
   fxn improved
   -consider head CT to eval for brain mets should pt require additional
   systemic anticoagulation
   .
   #Dysphagia - c/f esophageal CA vs. lung CA with extrinsic esophageal
   compression (in light of weight loss, h/o ETOH/tob use); significant
   risk factor for aspiration; hiatal hernia appreciated on CXR
   - attempt NG tube placement today
   -GI C/S re: utility of EGD when clinically more stable
   -aspiration precautions
   -consider speech/swallow C/S when more stable
   .
   #COPD - no si/sx acute exacerbation
   -admitted on prednisone taper; cont. as initial c/f AI in the setting
   of hypotension
   -cont. outpatient INH meds
   -albuterol nebs PRN
   -chest PT
   -INH moisturized air for dry mouth
   -Incentive spirometry
   .
   #HTN
   -holding antihypertensives while BP low
   .
   #Hyperlipidemia
   -holding crestor [**3-16**] elevated LFT's
   #Chronic back pain
   -lidocaine patch
   -avoid NSAIDs, ibuprofen since ARF and report of guaiac + on admission
   -avoid tylenol since LFTs elevated
 if required can have 2g max per
   day.
   .
   #F/E/N
   -LR boluses (in light of hyperchloremia) to maintain CVP, MAP, UOP as
   above
   - attempt NG tube placement today
   .
   #PPx - PPI, SQH
   .
   #Access - R IJ, PIV; art-line
   .
   #Contact/HCP - [**Name (NI) 121**], granddaughter ([**Telephone/Fax (1) 122**] (HCP)
   patient's home phone ([**Telephone/Fax (1) 123**]
   #Code status - FULL (per discussion with patient and HCP)
   ICU [**Name (NI) 151**]
   Nutrition:
   Glycemic Control:
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is an 80-year-old male with a history of coronary artery disease, cerebrovascular accident, hypertension, chronic obstructive pulmonary disease (COPD), and cancer metastatic to the liver. He was admitted with respiratory distress, sepsis, and hypotension.

The patient's vital signs are as follows:

* Temperature: 37.6°C (99.6°F)
* Heart rate: 117 beats per minute (bpm)
* Blood pressure: 93/53 mmHg
* Respiratory rate: 20 breaths per minute (bpm)
* Oxygen saturation: 100%

The patient's laboratory results show:

* White blood cell count: 21.8 x 10^9/L
* Hemoglobin: 9.8 g/dL
* Platelet count: 93 x 10^9/L
* Blood urea nitrogen (BUN): 154 mg/dL
* Creatinine (Cr): 2.6 mg/dL
* Lactic acid: 2.7 mmol/L
* Albumin: 2.1 g/dL
* Alkaline phosphatase (Alk Phos): 600 IU/L
* Amylase: 155 IU/L
* Lipase: 284 IU/L
* Troponin-T: 0.02 ng/mL
* C-reactive protein (CRP): 119 mg/L

The patient's medical conditions include:

* Sepsis: Most likely caused by aspiration pneumonia or post-obstructive pneumonia from primary lung cancer, hepatobiliary source, or Clostridium difficile.
* Respiratory failure: The patient requires mechanical ventilation.
* Metabolic acidosis: The patient has a mixed acid-base disorder with a pH of 7.35, partial pressure of carbon dioxide (PaCO2) of 28 mmHg, and partial pressure of oxygen (PaO2) of 74 mmHg.
* Cardiac failure: The patient has a low blood pressure and a high heart rate, indicating cardiac dysfunction.
* Acute kidney injury (AKI): The patient has a BUN/Cr ratio of 59, indicating pre-renal azotemia.
* Cholestatic liver dysfunction: The patient has elevated alkaline phosphatase and bilirubin levels.

The patient's medications include:

* Azithromycin
* Piperacillin/tazobactam (Zosyn)
* Vancomycin
* Heparin sodium
* Norepinephrine
* Pantoprazole (Protonix)
* Morphine sulfate

The patient's plan includes:

* Repeat echocardiogram to evaluate acute changes in cardiac function
* Titrate fluids to central venous pressure (CVP) 8-12 mmHg and mean arterial pressure (MAP) >65 mmHg
* Obtain blood and urine cultures
* Consider pulmonary embolism (PE) as an obstructive cause for tachycardia
* Restart heparin infusion
* Consider head computed tomography (CT) to evaluate for brain metastases
* Attempt nasogastric (NG) tube placement
* Continue antibiotics and antifungal therapy
* Monitor for signs of sepsis and adjust therapy accordingly.

Potential medical complications that can arise include:

* Sepsis: The patient is at high risk for sepsis due to his underlying medical conditions and the presence of a central line.
* Respiratory failure: The patient's respiratory status is critical, and he requires close monitoring and management.
* Cardiac failure: The patient's cardiac function is compromised, and he is at risk for further deterioration.
* AKI: The patient's kidney function is impaired, and he is at risk for further decline.
* Cholestatic liver dysfunction: The patient's liver function is compromised, and he is at risk for further deterioration.
* Pulmonary embolism: The patient is at risk for PE due to his immobility and the presence of a central line.

In conclusion, the patient is a critically ill individual with multiple underlying medical conditions and complications. He requires close monitoring and management to prevent further deterioration and to improve his chances of survival."
182947.0,210248,2182-08-27 09:31:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   ECHO done to eval EF and source of hypotension--preserved LVEF seen,
   impaired RV function seen and concern for left hilar mass noted.
   CT Chest done--6x8cm left hilar mass with extensive adenopathy seen.
   Left lower lobe collapse noted as well.
   Hypotension--recurrent and persistent across the day/night.  This is
   likely a combination of relative hypovolemia and impaired systemic
   vascular resistance secondary to infection, capillary leak and
   malignancy.  He has moved to the point of requiring pressor support to
   maintain adequate BP.
   Family updated in full with evolution of the worsening clinical status
   and findings on CT scan
                          History obtained from [**Hospital 19**] Medical records
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-27**] 08:00 AM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.09 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-27**] 08:00 AM
   Morphine Sulfate - [**2182-8-27**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 09:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 118 (116 - 125) bpm
   BP: 82/45(61) {82/43(61) - 101/53(69)} mmHg
   RR: 25 (20 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
   CVP: 9 (4 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
                                Total In:
                                                                  4,377 mL
                                                                  1,368 mL
   PO:
                                TF:
   IVF:
                                                                  4,377 mL
                                                                  1,368 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    200 mL
   Urine:
                                                                    679 mL
                                                                    200 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,168 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 99%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   General Appearance: Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Not assessed), (Left DP pulse: Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Dullness : ),
   (Breath Sounds: Diminished: ), Increased labored breathing
   Abdominal: Soft
   Extremities: Right: 1+, Left: 1+
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Verbal stimuli,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   9.8 g/dL
   193 K/uL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 yo admit with new findings of substantial evidence of malignancy
   based on imaging but without tissue diagnosis.  The initial
   presentation of sepsis has hard to define source and he now has
   evolution of worsening hypotension despite fluid resuscitation to the
   point of moderate pulmonary edema and pleural effusions.  In this state
   he has had further cardiovascular compromise to the point of requiring
   pressor support.  In this setting and in light of the Chest CT scan
   findings we have requested input from Oncology to consider if any
   therapeutic intervention for possible diagnoses of malignancy would be
   available.  Given his current functional status chemotherapy would not
   be a reasonable option has been the suggestion with which we would
   concur.  We have updated the family extensively as to the difficult
   situation with clinical compromise which has failed to completely
   resolve with treatment of infection--this may be in part attributable
   to the compromised functional status but does leave him not a candidate
   for chemotherapy Rx and is not medically stable enough to tolerate
   definative biopsy to guide that therapy.  These issues have been
   discussed in detail with the patient and his family.
   1)Sepsis
   -Azithro/Vaco/Zosyn
   -Continue with hydrocortisone
   -Patient will have pressors titrated to MAP >65
   2)Respiratory Failure
   -face mask for O2 delivery
   -Patient will have fluid balance optimized and pressors used for BP
   support
   -Rx for PNA
   -[**Month (only) 8**] move to right side down position given left lower lobe collapse.
   -Pleural effusions are present but unlikely to be causing ventilatory
   compromise
   3)Tachycardia-
   -Heparin restarted with concern for PE
this remains possible but
   certainly alternative causes are present to explain tachycardia
will
   stop infusion if evidence of bleeding is seen.
   -Will look to minimize the B-agonists as possible triggers of the
   tachcardia in the setting of pressor support.
   4)Malignancy
strongly suggeted by imaging.  He has mediatinal mass
   which may be appropriate target for biopsy in general but in his
   current clinical condition is not considered medically stable to
   tolerate procedure.  In addition, should a diagnosis be made he would
   not be able to tolerate chemotherapy which would not be offered given
   his current clinical status.
   5)ICU
Patient with worsening clinical status despite optimal efforts at
   treating reversible causes of his decline.  Have reached a point of
   inability to generate clinical improvement and in fact he has shown
   clinical decline.  Family meeting scheduled for today with the wife
   present to discuss grave prognosis and current goals of care.
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: Boots
IV Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 60 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Sepsis
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
 EKG - At [**2182-8-26**] 09:46 AM
 EKG - At [**2182-8-27**] 01:20 AM
   ECHO done to eval EF and source of hypotension--preserved LVEF seen,
   impaired RV function seen and concern for left hilar mass noted.
   CT Chest done--6x8cm left hilar mass with extensive adenopathy seen.
   Left lower lobe collapse noted as well.
   Hypotension--recurrent and persistent across the day/night.  This is
   likely a combination of relative hypovolemia and impaired systemic
   vascular resistance secondary to infection, capillary leak and
   malignancy.  He has moved to the point of requiring pressor support to
   maintain adequate BP.
   Family updated in full with evolution of the worsening clinical status
   and findings on CT scan
                          History obtained from [**Hospital 19**] Medical records
   Allergies:
   No Known Drug Allergies
   Last dose of Antibiotics:
   Azithromycin - [**2182-8-25**] 08:28 AM
   Piperacillin - [**2182-8-25**] 10:51 AM
   Vancomycin - [**2182-8-25**] 10:52 AM
   Piperacillin/Tazobactam (Zosyn) - [**2182-8-27**] 08:00 AM
   Infusions:
   Heparin Sodium - 550 units/hour
   Norepinephrine - 0.09 mcg/Kg/min
   Other ICU medications:
   Pantoprazole (Protonix) - [**2182-8-27**] 08:00 AM
   Morphine Sulfate - [**2182-8-27**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2182-8-27**] 09:15 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.6
C (99.6
   Tcurrent: 36.7
C (98
   HR: 118 (116 - 125) bpm
   BP: 82/45(61) {82/43(61) - 101/53(69)} mmHg
   RR: 25 (20 - 26) insp/min
   SpO2: 99%
   Heart rhythm: ST (Sinus Tachycardia)
   Height: 70 Inch
   CVP: 9 (4 - 10)mmHg
   Mixed Venous O2% Sat: 62 - 69
                                Total In:
                                                                  4,377 mL
                                                                  1,368 mL
   PO:
                                TF:
   IVF:
                                                                  4,377 mL
                                                                  1,368 mL
   Blood products:
   Total out:
                                                                    679 mL
                                                                    200 mL
   Urine:
                                                                    679 mL
                                                                    200 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                  3,698 mL
                                                                  1,168 mL
   Respiratory support
   O2 Delivery Device: High flow neb
   SpO2: 99%
   ABG: 7.35/28/74/12/-8
   PaO2 / FiO2: 123
   Physical Examination
   General Appearance: Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (S1: Normal), (S2: Distant)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Not assessed), (Left DP pulse: Not assessed)
   Respiratory / Chest: (Expansion: Symmetric), (Percussion: Dullness : ),
   (Breath Sounds: Diminished: ), Increased labored breathing
   Abdominal: Soft
   Extremities: Right: 1+, Left: 1+
   Skin:  Not assessed
   Neurologic: Follows simple commands, Responds to: Verbal stimuli,
   Movement: Not assessed, Tone: Not assessed
   Labs / Radiology
   9.8 g/dL
   193 K/uL
   154 mg/dL
   2.5 mg/dL
   12 mEq/L
   4.7 mEq/L
   88 mg/dL
   119 mEq/L
   145 mEq/L
   29.5 %
   24.7 K/uL
        [image002.jpg]
                             [**2182-8-25**]  03:03 AM
                             [**2182-8-25**]  12:31 PM
                             [**2182-8-26**]  01:31 AM
                             [**2182-8-26**]  06:33 AM
                             [**2182-8-26**]  03:53 PM
                             [**2182-8-26**]  09:46 PM
                             [**2182-8-26**]  11:53 PM
                             [**2182-8-27**]  01:45 AM
                             [**2182-8-27**]  02:55 AM
                             [**2182-8-27**]  04:48 AM
   WBC
   21.8
   23.8
   23.6
   24.7
   Hct
   31.6
   29.7
   29.8
   29.5
   Plt
   [**Telephone/Fax (3) 158**]93
   Cr
   2.6
   2.5
   2.5
   2.5
   TropT
   0.02
   0.03
   TCO2
   15
   15
   13
   15
   15
   16
   Glucose
   138
   140
   136
   154
   Other labs: PT / PTT / INR:26.9/92.1/2.7, CK / CKMB /
   Troponin-T:118/6/0.03, ALT / AST:116/201, Alk Phos / T Bili:600/2.8,
   Amylase / Lipase:155/284, Differential-Neuts:88.0 %, Band:0.0 %,
   Lymph:5.3 %, Mono:6.6 %, Eos:0.1 %, Lactic Acid:2.7 mmol/L, Albumin:2.1
   g/dL, LDH:495 IU/L, Ca++:8.2 mg/dL, Mg++:2.5 mg/dL, PO4:4.4 mg/dL
   Assessment and Plan
   80 yo admit with new findings of substantial evidence of malignancy
   based on imaging but without tissue diagnosis.  The initial
   presentation of sepsis has hard to define source and he now has
   evolution of worsening hypotension despite fluid resuscitation to the
   point of moderate pulmonary edema and pleural effusions.  In this state
   he has had further cardiovascular compromise to the point of requiring
   pressor support.  In this setting and in light of the Chest CT scan
   findings we have requested input from Oncology to consider if any
   therapeutic intervention for possible diagnoses of malignancy would be
   available.  Given his current functional status chemotherapy would not
   be a reasonable option has been the suggestion with which we would
   concur.  We have updated the family extensively as to the difficult
   situation with clinical compromise which has failed to completely
   resolve with treatment of infection--this may be in part attributable
   to the compromised functional status but does leave him not a candidate
   for chemotherapy Rx and is not medically stable enough to tolerate
   definative biopsy to guide that therapy.  These issues have been
   discussed in detail with the patient and his family.
   1)Sepsis
   -Azithro/Vaco/Zosyn
   -Continue with hydrocortisone
   -Patient will have pressors titrated to MAP >65
   2)Respiratory Failure
   -face mask for O2 delivery
   -Patient will have fluid balance optimized and pressors used for BP
   support
   -Rx for PNA
   -[**Month (only) 8**] move to right side down position given left lower lobe collapse.
   -Pleural effusions are present but unlikely to be causing ventilatory
   compromise
   3)Tachycardia-
   -Heparin restarted with concern for PE
this remains possible but
   certainly alternative causes are present to explain tachycardia
will
   stop infusion if evidence of bleeding is seen.
   -Will look to minimize the B-agonists as possible triggers of the
   tachcardia in the setting of pressor support.
   4)Malignancy
strongly suggeted by imaging.  He has mediatinal mass
   which may be appropriate target for biopsy in general but in his
   current clinical condition is not considered medically stable to
   tolerate procedure.  In addition, should a diagnosis be made he would
   not be able to tolerate chemotherapy which would not be offered given
   his current clinical status.
   5)ICU
Patient with worsening clinical status despite optimal efforts at
   treating reversible causes of his decline.  Have reached a point of
   inability to generate clinical improvement and in fact he has shown
   clinical decline.  Family meeting scheduled for today with the wife
   present to discuss grave prognosis and current goals of care.
   ICU Care
   Nutrition:
   Glycemic Control:  Regular insulin sliding scale
   Lines:
   Presep Catheter - [**2182-8-23**] 12:59 AM
   Arterial Line - [**2182-8-23**] 08:04 PM
   Prophylaxis:
   DVT: Boots
IV Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 60 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, I summarize the patient's health progress in the ICU as follows:

The patient, an 80-year-old male, was admitted with new findings of substantial evidence of malignancy based on imaging but without tissue diagnosis. He initially presented with sepsis, which has evolved into worsening hypotension despite fluid resuscitation, leading to moderate pulmonary edema and pleural effusions. The patient has required pressor support to maintain adequate blood pressure.

The patient's vital signs are:

* Temperature: 37.6°C (99.6°F)
* Heart rate: 118 bpm
* Blood pressure: 82/45 mmHg
* Respiratory rate: 25 inspirations per minute
* Oxygen saturation: 99%
* Hemodynamic monitoring: CVP 9 mmHg, mixed venous O2% saturation 62-69%

The patient has undergone various diagnostic tests, including:

* EKG: Sinus tachycardia
* ECHO: Preserved LVEF, impaired RV function, and concern for left hilar mass
* CT Chest: 6x8cm left hilar mass with extensive adenopathy and left lower lobe collapse
* Blood tests: Elevated WBC, Hct, and lactate levels; decreased platelet count

The patient's condition is complicated by:

* Sepsis, which has failed to resolve with treatment of infection
* Respiratory failure, requiring oxygen therapy and mechanical ventilation
* Tachycardia, possibly related to sepsis or pulmonary embolism
* Malignancy, strongly suggested by imaging, but not yet confirmed by tissue diagnosis
* ICU care, with multiple lines and prophylactic measures in place

The patient's plan of care includes:

* Continuing antibiotics (Azithro/Vaco/Zosyn) and hydrocortisone
* Titrating pressors to maintain mean arterial pressure (MAP) >65 mmHg
* Optimizing fluid balance and pressors for BP support
* Managing respiratory failure with face mask oxygen delivery and possible pleural effusion drainage
* Monitoring for and treating potential complications, such as pulmonary embolism and bleeding

Given the patient's critical illness and lack of medical stability, a family meeting has been scheduled to discuss the grave prognosis and current goals of care."
